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Abstract 
Hereditary non-polyposis colorectal cancer (HNPCC) is an autosomal dominant 
condition that predisposes individuals to colon and other cancers. Genetic testing is 
available to families with known mutations. Limited insight exists on situational and 
contextual factors influencing genetic testing, as well as the reaction to and acceptance of 
one's results. An original qualitative study used grounded theory methodological to 
explore the meaning of genetic testing for HNPCC, to develop a greater understanding of 
the psychosocial and behavioural impact for carriers and non-carriers, and to identify 
relevant information to facilitate the provision of counseling programs for both 
individuals and families. A substantive theory, Con.fi-onting and Accepting the Challenges 
of Living in Families with Genetic Linked Diseases, emerged from the data analysis. This 
theory is defined by three major thematic categories - living in families with a strong 
history of cancer, becoming aware of genetic testing and living the process, and 
struggling to adjust. 
Most of the participants in the original study were from families with the intron 5 
splice site of the MSH2 gene. These individuals had participated in genetic testing eight 
to ten years prior to being interviewed. With the identification of an additional MSH2 
mutation, exon 8 deletion, family members were now available to be interviewed closer 
to the time of genetic testing. A modified grounded theory study was subsequently 
conducted with these individuals by this researcher. The purpose of the current study was 
to augment the conceptualizations leading to the substantive theory generated in the 
original study. 
Ill 
The findings indicated that the genetic testing event was viewed narrowly in 
comparison to the larger life context. The importance of lay inheritance beliefs became 
integral to shaping the meaning of genetic testing. Family experiential knowledge 
emerged as a major factor in shaping risk perceptions and emotional readiness. The 
impact of these experiences requires careful assessment before genetic testing. Pre-test 
genetic counseling enJ1anced cognitive processing of results, but unexpected emotional 
reactions occurred in relation to extensiveness of familial cancer, beliefs about 
inheritance, coping abilities, and fam ily communication. Attention needs to be given to 
the impact of subjective feeling states on the testing process. The psycho-emotional 
impact of knowing one' s HNPCC status can impede successful coping long-te1m. Being 
open to and having family support emerged as being significant. Timing and sites of 
recommended cancer screening were variable amongst physicians, suggesting the value 
of accurate timely information flow. For carriers reaching the affected tage, access to 
health care becomes increasingly s ignificant. 
In conclusion, clinicians and families need to think longitudinally about the 
course of 1--INPC illness with normative landmark transitions and constantly changing 
demands to help individuals achieve a sense of resilience and maintain an optimal quality 
of life. Nurses are poised to prioritize, coordinate, and provide p ychological and 
emotional support to 1-JNPCC famili es. 
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CHAPTER 1 
Introduction 
Hereditary non-polyposis colorectal cancer (HNPCC) is an autosomal dominant 
syndrome associated with one of five germ-line mutations (hMSH2, hMLHI, PSMl , 
PMS2 and hMSH6) that predisposes individuals to colon and other associated cancers 
(Lynch, Lynch, Lynch, & Attard, 2008). Autosomal dominant means that only one 
parent needs to pass the abnormal gene fo r HNPCC onto offspring for them to inherit the 
syndrome. The syndrome is characterized by early age of cancer onset and carries a 
significant lifetime risk for colorectal cancer (CRC) (80%-90% ), endometrial cancer ( 40-
60%), and ovarian cancer (1 2-15%) (Lynch et al. , 2008). It is also associated with an 
increased risk of kidney, gastric, urothelial cancer, biliary tract, small intestine, brai n and 
skin tumours (Aarino et al., 1999; Chung & Rustgi, 2003; Green et al. , 2002; Stuckless et 
al., 2007). 
Individuals from families with a known HNPCC gene mutation are encouraged to 
participate in at-risk testing upon reaching the age of informed consent. Genetic testing 
will determine individual famil y member's risk status for the condition but not if or when 
it will surface. Defining features of the HNPCC syndrome are incomplete penetrance (not 
all mutation carriers will develop a cancer) and variable expressivity (carriers develop 
different cancers at different ages) (Brodersen, Sutton, Goff, Hodgson, & Thomas, 2004; 
Lindor et al. , 2006; Stuckless et al. , 2007). Following geneti c testing, carriers are alerted 
to the importance of continuing or initiat ing screening for the prevention and early 
detection of associated cancers, while non-carriers can be relieved from the burden of 
unnecessary screening (Aarino et al. , 1999; Lin et al. , 1998; Lynch & Chapelle, 2003 ; 
Vasen et al. , 1998). 
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The full extent and specifics of the psychosocial and behavioural impacts of 
genetic testing for HNPCC on individuals and families are still unknown despite the 
expanding research base in this area. Limited insight also exists on how personal 
understandings of hereditary based cancer and situational and contextual factors influence 
an individual's decision making prior to and following genetic testing for HNPCC 
(Bleiker, Hahn, & Aaronson, 2003; Marteau & Weinman, 2006; McAllister, 2002, 2003 ; 
Meiser, 2005; Murakami et al. , 2004). An important contextual factor that seems to 
buffer the impact of genetic testing on family members is strong and open 
communication patterns (Rolland & Williams, 2005; van Oostrom et al. , 2007a). 
Currently, researchers and theorists are placing more emphasis on exploring how 
variations in the family context may impact short- and long-term adjustment for those at 
risk for HNPCC (Gaff, Collins, Symes, & Halliday, 2005; Koehly et al. , 2003 ; Lim, 
Macluran, Price, Bennett, & Butow, 2004; McAllister, 2002; Mesters, Ausems, E ichhorn, 
& Vasen, 2005; Peterson et al. , 2003; Rolland & Williams, 2005). 
Overall, the results of systematic reviews and meta-analyses of both controlled 
and uncontrolled trials on the psychological and behavioural effects of genetic testing for 
familial cancers suggest that genetic testing has no major effect on an individual 's level 
of general anxiety or cancer-specific worry (Bleiker et al. , 2003; Braithwaite, Emery, & 
Walter, 2004; Meiser, 2005). In fact, prospective data specific to the HNPCC population 
suggest decreases in general anxiety and cancer-specific worry by the three and six-
month time points post-genetic testing. Despite this favourable evidence, researchers note 
the dearth of knowledge in the area of genetic testing for HNPCC and recommend that 
more extensive research be conducted to determine its true effects on the individual and 
the family unit in both the short- and long-term. Many advocate for the use of a 
qualitative approach (Bieiker et al., 2003; Marteau & Weinman, 2006; McAllister, 200 1; 
Riper, 2005). 
Background and Rationale 
3 
Previous studies on genetic testing for cancer conditions have primarily focused 
on hereditary breast and fiNPCC populations. Studies on HNPCC have mai nly attempted 
to gain greater insight into the factors that relate to decision making around genetic 
testing and the psychosocial and behavioural impacts of this experience in the short-term. 
Study findings concur that such psychological factors as personal cancer worry and 
perceived high risk for the disease, as well as concern for children and close family 
members, pos itively impact interest and engagement in genetic testing (Braithwaite et al. , 
2004; Claes, Denayer, Evers-Kiebooms, Boogaerts, & Legius, 2004; C laes et al., 2005; 
Meiser et al. , 2005). 
There is also emerging evidence on the relevancy of the family context for 
shaping risk perceptions in the pre-genetic testing phase and influencing acceptance of 
and adjustment to genetic test results (d' Agincourt-Canning, 2005; Kenen, A rden-Jones, 
& Eeles, 2003; McAllister, 2001 , 2002; Shiloh, 2006). Nevertheless, study findings 
generated by standardized scales indicate minimal psychological and emotional harm 
from genetic testing for both carriers and non-carriers. The findings a lso suggest that 
anxiety and distress levels rise briefly at the time of genetic testing and usuall y subside 
within a year after testing for carriers (Aktan-Collan, Haukkala, Mecklin, & Kaariainen, 
2001; Braithwaite, Emery, & Walter, 2004; Claes et al., 2004; Claes et al. , 2005; Meiser, 
2005). 
Study findings also suggest that there are a range of complex concerns not being 
considered in the assessment of an individual ' s overall adjustment to genetic testing. 
Coping strategies, experiential knowledge about cancer risk in the family, the 
development of risk perceptions during the years prior to testing, and family impacts 
appear to have significant effects on adjustment in the long-term (Braithwaite et al. , 
4 
2004; Heshka, Palleschi, Howley, Wilson, & Wells, 2008; Meiser, 2005). Studies 
evaluating the behavioural outcomes of testing are largely quantitative and focus on 
screening rates among carriers post-testing. Yet there is a growing body of research 
highlighting the barriers to screening adherence and the importance of the health care 
system in facilitating this for carriers (Geary et al., 2007; Lindor et al. , 2006; Lynch et a l. , 
2008). 
Nevertheless, what appears to be absent is reliable and va lid measures for 
assessing important factors, such as the years spent living in a high-ri sk family, that shape 
individuals' willingness to engage in genetic testing and how they experience the process. 
Equally important is the limited research conducted on individual and family adjustment 
years after testing. The studies designed to assess short- and long-term adj ustment use 
standardized sca les for measuring outcomes such as anxiety, depression and self-efficacy, 
yet there are only a few designed to measure factors specific to genetic testing for cancer 
syndromes (Balmana Stoffel, Emmons, Garber, & Syngal. , 2004; Pieterse et a l. , 2005). 
More substantive theory development, through the use of grounded theory me thodology, 
,-----------------------------
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is needed to provide a database for generating reliable and valid operational measures of 
key factors believed to exert a mediating and moderating impact on overall adjustment 
(Coyle & Williams, 2000; Gilgun, 1992, 2004; McAllister, 200 1; Way et al., 2008). More 
importantly, in order to ensure that individuals, families and health care professionals 
have a full understanding of the implications of genetic testing for HNPCC, it is 
imperative that we explore the full scope of the experience including the many years 
preceding and following the genetic testing event. 
Significance and Problem Statement 
A large case control study conducted in the provinces of Ontario (ON) and 
Newfoundland (NL) examined the genetic epidemiology ofCRC and its psychosocial 
component, investigating the impact of genetic testing for 1-INPCC both quantitatively 
and qualitatively (Way et al., 2008). The results of the initial quantitative study suggested 
that personal characteristics such as time since HNPCC testing, age, gender, family 
frequency of CRC, and affected and non-affected status did not have a significant impact 
on lifestyle changes, adjustment difficulties or emotional status following genetic testing. 
Interestingly, participants with a greater CRC presence in the fami ly were less likely to 
experience such negative emotions as cancer worry and guilt. 
A follow-up qualitative study was designed to explore the meaning of genetic 
testing for 1-INPCC, to develop a greater understanding of the psychosocial and 
behavioural impact for carriers and non-carriers, and to identify relevant info rmation to 
fac ilitate the provision of counseling programs for both ind ividuals and families (Way et 
al. , 2008). A substantive theory entitl ed, Confronting and Accepting the Challenges of 
6 
Living in Families with Genetic Linked Diseases, emerged from the data analysis. This 
theory is defined by three major thematic categories - living in families with a strong 
history of cancer, becoming aware of genetic testing and living the process, and 
struggling to adjust. It proposes that living in families with a strong history of cancer and 
becoming aware of genetic testing and living the process exert both a direct and an 
indirect effect on adjustment to a HNPCC carrier or non-carrier status. It also conjectures 
that each construct exerts a separate and interactive effect on quality outcome. 
Most of the participants in the original qualitative study had undergone genetic 
testing eight to ten years prior to being interviewed. Targeted individuals were from the 
12 families with a known germ line mutation on the mismatch repair MSH2 gene - splice 
site of intron 5 which results in exon 5 deletion (Green et al. , 2002; Stuckless et al., 
2007). However, during the course of the study, further analysis of other high-risk 
families resulted in the identification of a second MSH2 gene mutation - deletions of 
exon 8 in five families. What this meant for the larger research study is that family 
members were potentially available to the research team who had experienced genetic 
testing more recently. This discovery also coincided with changes noted in the prevalence 
of other types of cancers in these families. Exon 8 deletion mutation family members 
were being counselled to pay patiicular attention to other cancers, such as kidney and 
urothelial cancers. The health system had also integrated genetic counselors into the 
provincial medical genetics program. Thus, new referrals for genetic testing for HNPCC 
were now being offered information and advice from both the geneticist and genetic 
counselors. It was necessary to capture the experiences of individuals more recently 
tested for HNPCC in order to confirm the substantive theory. 
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CHAPTER2 
Literature Review 
Research in cancer and genetics has identified several mutations associated with 
the development of HNPCC. Close to I 000 HNPCC families have been recognized 
worldwide and many other families at risk are being followed clinically every day. The 
identification of a genetic mutation provides an opportunity for individuals in high-risk 
families to confirm their cancer risk and to engage in preventative and early detection 
screening programs to help control disease progression. Research to date suggests regular 
screening decreases morbidity and mortality (Bleiker et al., 2003; Jarvinen et al. , 2000). 
Nevertheless, very little is known about what it is like to live with knowledge of a 
hereditary link to cancer in the family. Health care professionals need to be confident that 
providing cancer risk information to individuals has minimal psychosocial and emotional 
impact in the short- and long-term. 
Research on genetic testing for HNPCC is largely quantitative, although a few 
qualitative studies provide a richer representation of the experience. This literature review 
explores the entire genetic testing experience (i.e. , the lead-in, actual and post-test 
periods). First, it provides an overview of research studies conducted on the lead-in 
period to genetic testing for hereditary cancer. Second, it explores the actual genetic 
testing period, which includes the preparation for and reaction to the receipt of test results 
and the perceived level and quality of communication within families following 
confirmation of a H PCC gene mutation. Finally, it provides a discussion of key issues 
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in the post-test period. Specifically, the discussion will focus on the impact on the family 
and others, screening practices, and the need to confront new issues beyond the self. 
The Lead-in Period 
The lead-in period refers to the months and years prior to genetic testing for 
hereditary cancer. For some individuals, the period is marked by significant family losses 
from cancer fo llowed by the notion that one could also be at risk. For others, fami ly 
losses from cancer are less pervasive and therefore little thought is given to one's 
personal risk status. Although few studies explore the years prior to testing in-depth, the 
importance of events occurring during this time for full engagement in the genetic testing 
process are recurring themes in the literature (Bieiker et al. , 2003; McAllister, 2002, 
2003 ; McAll ister, Davies, Payne, Nicho lls, Donnai, & MacLeod, 2007; McCann et al., 
2009). 
Familial Experiential Context 
The relevancy of the family context for shap ing individuals' bel iefs about cancer 
transmission and what implications this might have personally has been recognized as 
important in the development of risk perceptions for genetic-ba ed diseases. Several 
studies have focused on developing greater insight into the meaning and importance of 
this context fo r facil itating acceptance of the genetic link to cancer and willingness to 
engage in the genetic testing process. It is conjectured that the impact of the family 
context can be quite vari able for different individuals depending on their closeness to and 
degree of involvement with cancer illness in family members, and/or personal 
experiences with cancer (d' Agincourt-Canning, 2005; Kenen, et al., 2003; McAllister, 
2001, 2002; Shiloh, 2006). 
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In a qualitative study of women's experiences with hereditary breast and ovarian 
cancer, d ' Agincourt-Canning (2005) concluded that participants' conceptualizations of 
personal risk seemed to be informed by two types of knowing - emphatic and embodied. 
Emphatic knowing is defined as a continuum of knowing that is informed by stories 
relayed to a person by others and/or close/distant encounters with family members who 
have or have had cancer. Embodied knowing is defined in terms of how cancer and its 
treatment are experienced within the self. The frequency and intensity of encounters with 
or the stories about others are conjectured to have far-reaching implications for 
individuals ' understandings and knowledge of cancer. As well, personal experiences with 
cancer tend to augment pre-existing knowledge and understandings derived from prior 
encounters with or memories of others' experiences with cancer. 
An important aspect of perceived risk for cancer, which is grounded in a 
familial/personal experiential base, is that it is continuously evolving, albeit in a non-
linear manner. As such, each new encounter with cancer in other family members or on a 
personal level rekindles what lies dormant during disease-free periods. What is 
conjectured to be salient for risk constructions is how one interprets the meaning of these 
experiences for the self (Way et al. , 2008). In a qualitative study of women with a family 
history of hereditary and ovarian cancer, Kenen et al. (2003) found that risk perceptions 
were constructed by piecing together family cancer experiences in a highly selective 
manner from story fragments vaguely remembered and/or secret stories unearthed while 
searching for an wers. Significantly, interpretations of a particular family ' s cancer history 
seemed to be more important in shaping risk perceptions than actual familial cancer 
patterns. 
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McAllister's (2002) theory of engagement captures the process of engaging in 
risk for HNPCC. The degree of engagement in HNPCC risk is conjectured to vary over 
time in relation to the level of cognitive and emotional involvement with the family's 
history of cancer. At any point in time, individuals fall along a continuum marked by 
disengagement or partial/intense engagement. Individuals are more likely to evidence 
partial engagement with their risk if they are ignorant ofthe fan1ily history, have 
impersonal knowledge of this history, have sporadic experiences with cancer in family 
members, or live in families where cancer is a taboo. McAllister (2002) suggests that the 
degree of engagement with HNPCC risk is a function of the openness of discussions 
about the family history in response to the unfolding of cancer events. 
Risk Perceptions and Pre-genetic Testing Engagement 
Risk perception takes on new meaning when an individual is first introduced to 
the idea that the cancer observed or experienced in one's family is potentially due to 
genetic factors. Several authors noted a discrepancy between knowing about the family 
history of cancer and thinking about the possibility that this might be inherited versus 
becoming informed about the potential genetic link and understanding how this could 
impact personal risk perceptions for the disease (McAllister, 2003 ; Reeve, Owens, & 
Winship, 2000). Study findings suggest that individuals whose lives are affected by 
familial cancer seek explanations about possible causal factors. 
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Many families at risk for HNPCC tend to use rudimentary inheritance patterns to 
seek answers to and to cope with their own potential risk status (Kenen et al. , 2003; 
McAllister, 2002, 2003; Targum, 2000). In many instances, individuals tend to 
overestimate their risk, which may in part be attributed to the closeness and severity of 
cancer episodes experienced in the family. In contrast, individuals tend to underestimate 
risk if they perceive the family cancer as not severe or they are unaware of its presence. 
Either way, awareness and experiential knowledge play a significant role in the 
development of personal risk perceptions and hence may have a strong influence on 
coping strategies to deal with the event (McAllister, 2001 ). 
Carlsson and Nilbert's (2007) and McAllister' s (2003) qualitative inquiries 
demonstrate the importance of awareness of hereditary cancer in the family for 
engagement in HNPCC risk and, ultimately, the genetic testing process. Carlsson and 
Nil bert found that many study participants reported being suspicious of hereditary cancer 
long before confirmation of the HNPCC presence in the fan1ily. For many, it triggered the 
unexplained worry about cancer in the family that had been discussed over the years 
amongst parents and grandparents. Significantly, individuals unaware of the cancer 
hereditary link were overwhelmed by the news. McAllister (2003) described how family 
members develop narratives around their risk status to enable them to cope with the 
interaction of lay theories of inheritance, ideas about luck, past coping strategies and 
conviction about carrier status as a means of dealing with the decision to become 
involved in genetic testing. Assessment of the development of personal risk status and 
related coping abilities are important to consider in determining a person's emotional 
readiness for testing. 
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Beyond awareness of hereditary cancer prior to testing, experiential knowledge is 
another factor influencing the emotional readiness of individuals presenting for genetic 
testing for HNPCC. Carlsson and Nil bert (2007) noted that individuals who had cared for 
close family members reported experiencing emotional difficulties when first presented 
with the option of genetic testing for HNPCC. Similarly, McAllister (2002) noted that 
individuals who struggle with painful memories of having cared for and lost close family 
members may resist becoming engaged with their HNPCC risk. As this author noted, 
accounts of cancer stories are not just reflections of the past linked to emotions, but rather 
are post hoc justifications for beliefs and actions about a possible mutation carrier statu 
Past cancer experiences seem to be inextricably linked to coping strategies in complex 
ways. 
Summary 
It seems apparent that awareness of fami ly history, anxiety and worry, 
experiential knowledge and development of risk perceptions and coping strategies are all 
important factors that need to be considered in assessing individuals' emotional readiness 
for genetic testing. The importance of how these factors relate to one another in the 
evolution of events during the many years preceding testing becomes increasingly 
re levant to the impact of genetic testing for HNPCC. Currently, the literature fails to 
address the influences of living in a family with hereditary cancer on accepting the need 
for genetic testing for HNPCC and moving through the testing process. 
The lead-in period for genetic testing needs further exploration to determine how 
living in a family with an extensive cancer history influences individuals' reactions to the 
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ideas of HNPCC and genetic testing. Furthermore, we need greater insight into how a 
familial cancer history influences the meaning of cancer illness for the self and/or the 
development of personal risk perceptions. Finally, more infom1ation is required about 
how risk perceptions for future disease states influence acceptance of and adjustment to 
genetic test results in the short- and long-term. These components require more in-depth 
analysis using a broader conceptualization of the lead-in period to genetic testing for 
HNPCC. 
The Genetic Testing Period 
The genetic testing period refers to the preparation for the testing and counseling 
process, reactions and adjustment to the receipt of results, and willingness to 
communicate the findings of genetic testing patterns within fam ilies. Studies on the 
genetic testing period focus on evaluating the counseling process, the reactions and short-
term adjustment to learning about one's carrier status and the importance of 
communication within families (Bieiker et al. , 2003; Braithwaite, Emery, Walter, 
Prevost, & Sutton, 2006; Meiser, 2005; van Oostrom et al. , 2006b). 
Decision-Making for and Engagement in Genetic Testing 
A number of studies have been conducted on decision making around genetic 
testing, with many suggesting it is largely a cogniti ve process. Etchegary's (2004) review 
revealed that many of the studies in this area are descriptive, while a few researchers have 
used social cognition theory and, more recently, grounded theory to fu rther discern how 
and why individuals decide to undergo geneti c testing for HNPCC. All of the study 
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findings indicate that the decision-making process is intrinsically linked to the 
development of a healthy appreciation for ones' personal risk. 
Descriptive findings. Early descriptive studies on the decision to test focused 
primarily on extrapolating what factors motivate an individual to engage in the genetic 
testing process. Perceived risk of being a carrier, belief that cancer in the family is 
hereditary, the ability to handle the emotional aspects of testing, and the psychosocial 
effects that carrier status would have on other family members were found to be 
associated with the motivation to test (Bieiker et al. , 2003; Meiser, 2005). 
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Bleiker et al. 's (2003) review highlighted study findings on risk perceptions and 
motivations for genetic testing over the previous decade. An important finding was the 
significant influence of subjective risk as opposed to objective risk on genetic testing 
decision-making. Subjective risk is shaped by the family history of cancer, psychological 
distress and coping strategies, and family communications. As perceived susceptibility 
for cancer is often overestimated, it is conjectured that individuals seek genetic testing to 
reduce uncertainty, confirm the need for preventive actions, determine their children's 
risk, and plan for the future. Meiser' s (2005) and Etchegary's (2004) reviews of the 
literature on genetic testing for HNPCC and breast/ovarian cancer support Bleiker et al. 's 
(2003) findings. 
Higher education, younger age, being married, previous involvement with 
genetics services and less advanced stage of CRC have also been found to be predictive 
of a greater intention to test. However, some researchers have found that the frequency 
of intrusive thoughts about CRC being hereditary seems to be a stronger correlate of 
intention to test (Esplen, Urquhart, Butler, Gallinger, Aronson, & Wong, 2003; Esplen 
et al., 2007; Hadley et al., 2003; Kinney et al., 2000; Lerman et al. , 1999). Meiser 
(2005) also found that intention to engage in genetic testing appears to be more 
consistently associated with psychological factors than socio-demographic factors. 
16 
Despite consistent findings on interest in and intention to participate in genetic 
testing, concerns exist about the reliability of these early studies. Specifically, the use of 
single items to measure distress, worry, and intrusive thoughts and/or standardized scales 
not validated in populations with genetic-based diseases compromises the reliability and 
validity of the results (Bieiker et al., 2003; Braithwaite et al., 2006; Broadstock, Mitchie, 
& Marteau, 2000; Heshka et al. , 2008; Meiser, 2005; van Ostroom, 2006a, 2006b). As 
well , even though high rates of interest are reported, this does not necessari ly translate 
into high levels of engagement in genetic testing for HNPCC. Discrepancies may be due 
to change in knowledge about HNPCC, risk perceptions, perceived benefits, or the risks 
and limitations of genetic education and counsel ing (Claes et al. , 2004; Coyle & 
Williams, 2000; Heshka et a l. , 2008). 
Besides the research findings on motivators of genetic testing, a number of 
quantitative studies have investigated the psychosocial and emotional status of 
individuals prior to actua lly participating in the process (Bieiker et al. , 2003 ; Braithwaite 
et al. , 2006; Meiser, 2005). As noted previously, perceived risk for cancer is highly 
variable and heavily influenced by personal factors and the fam ily condition (d ' 
Agincour1-Canning, 2005; Kenen, et al. , 2003 ; McAllister, 2001 , 2002; Shiloh, 2006). 
Nevertheless, for the most par1, psychosocial and emotional states do not reach clinical 
levels during the pre-test period (Bieiker et al. , 2003; Braithwaite et al., 2006; Meiser, 
2005). 
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There is also some support for a strong association between elevated risk 
perceptions and higher levels of psychological distress (Bleiker et al. , 2003; Carlsson, 
Bjorvatn, Engebretsen, Berglund, & Natvig, 2004; Claes et al., 2005; Esplen et al., 2003). 
There is also some evidence suggesting that greater perceived social support (Carlsson & 
Nilbert, 2007; Esplen et al. , 2007) greater self-efficacy (Carlsson & Nilbert, 2007) and 
more positive coping styles (Claes et al. , 2005; Esplen et aJ., 2007) decrease distress 
levels. 
Genetic counseling is designed to improve disease prevention by providing 
genetic risk information to those at risk. During HNPCC counseling sessions individuals 
are given info1mation about the ongoing characterization of the condition, the variability 
of the di sease, the benefits and limitations of testing, potential impact on personal 
relationships and goals, and options for risk reduction through screening (Brodersen et 
al. , 2004; Lindor et al., 2006; McAllister, 2003 ; McAllister, Payne, MacLeod, N icholls, 
Donnai, & Davies, 2008b; Stuckless et al. , 2007). Individuals are also counseled on how 
to communicate test results to others and are given supportive counseling options (van 
Oostrom et al. , 2006a, 2006b, 2007). 
At present, clinical genetics services operate primarily under the principles of a 
knowledge sharing approach. The focus of counseling is on providing information about 
cancer inheritance and susceptibility, gene identification and the meaning of results 
largely from a Mendelian perspective. That is, individuals are counseled first about their 
risk for having the HNPCC gene mutation and second on their CRC and extracolonic 
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cancer risks (Am·nio et al., 1999; Jarvinen et al. , 2000; Lynch et al., 2008). McAllister, 
Payne, MacLeod, Nicholls, Donnai, and Davies (2008a) noted there is very little evidence 
that accurate information or risk figures per se are necessarily valued by patients. 
Theoretical insights. Social cognition models depict relationships between 
knowledge, beliefs, attitudes, and behavior. It is conjectured that decision-making is 
based on beliefs and consideration of these beliefs can help predict future health 
behavior. As HNPCC offers individuals a measure of disease control through 
preventative screening regimes, the application of these models are deemed to be 
valuable for identification of factors that relate to the decision to test (Etchegm·y, 2004; 
Marteau & Weinman, 2006; Shiloh, 2006). 
Shiloh's (2006) theoretical review of genetic counseling applies self regulation 
theory to the decision to test. The theory proposes that illness representations, defined as 
people's perceptions of and beliefs about an illness, mediate the relationship between 
health threats and reactions to them. Identity of the threat, cause, timeline, consequences 
and controllabi I i ty are key aspects. It is also proposed that the genetic testing decision-
making is underpinned by factors such as family influence, perceived benefits and health 
care professional influences. Illness representations evolve over time based on personal 
experiences with disease and social/cultural information acquired through various social 
sources. It follows that personal experiences with a genetic disease are major 
determinants of its representation and the decision to test. 
Marteau and Weinman (2006) similarly applied self-regulation theory to explain 
decis ion making and behavioral responses to learning about one' s carrier status. These 
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researchers highlighted that the decision to test and subsequent participation in screening 
depends on a range of factors, which include perceptions about tlu·eat, the likeliness of 
screening to reduce the threat and one's ability to engage in screening. The authors 
concluded that, although studies to date indicate consistent uptake of testing, few if any, 
have found support for appropriate increases in surveillance behavior following genetic 
counseling. 
With self-regulation theory, emphasi s is placed on the cognitive process in 
shaping the development of risk perception. Marteau and Weinman (2006) recommend 
further investigation of what motivates testing by focusing on enhanc ing the cognitive 
aspects of how information is presented to individuals and how the representation is 
translated into a behavioral response. ln contrast, qualitative evidence suggests that 
genetic testing is a lso an emotional process and further research is needed to explore the 
emotional aspects as a means of elucidating a broader picture of the influences on the 
decision to test. 
Qualitativefindings. Quantitative studies have documented the importance of 
both cognitive and emotional factors in det rmining a person's readine s for testing 
(McAllister et al. , 2007; van Oostrom, 2006a; 2006b). However, th focu in these 
studies remains on the individual to the exclu ion of the famil y context. Qualitative 
studies have explored the importance of the level of awareness of hered itary cancer, 
anxiety prior to testing, experientia l know! dge, ri sk perceptions and coping strategies in 
shaping individual readiness for and reaction and adjustment to genetic test results 
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(Carlsson & Nilbert, 2007; McAllister, 2002, 2003; McAllister et al., 2007; Reeve et al. , 
2000). 
Emotional readiness for predictive genetic testing for a variety of diseases has 
become increasingly the focus of qualitative inquiries. Reeve et al., (2000) qualitative 
study identified awareness of hereditary cancer in the family as an important part of one' s 
emotional readiness for testing. All participants spoke of the long-standing recognition of 
a family link with bowel cancer. For many it wa long before the idea of a cancer gen tic 
link was even considered in the medical field. Participants in this study had an overall 
positive attitude toward taking part in testing and adjusted well to news of their carrier 
status. These findings suggest a healthy awareness of a cancer genetic link is an 
important part of positive adjustment to genetic testing results. 
McAllister (2002) also suggested that engaging in genetic te ting may be difficult 
due to past experiences. Many of the participants in her study described painful memori s 
and emotional experiences with cancer diagnoses and /or death of a parent or close family 
members at an early age. These experiences seemed to play a key role in the decision 
making process. 
Anxiety and worry have also been exhibited amongst participants presenting for 
gene testing. arl on and Nil bert (2007) found that some of their participants reported 
feeling tense and worried before testing, postponing originally scheduled appointments, 
and/or needing time to mentally prepare before scheduling counseling sessions. Other 
participants di scussed how emotions related to a hereditary predi position to cancer were 
suppress d and how coping strategies, such as denial , projection, and distraction, were 
employed to spend less time reflecting on the awareness of the genetic defect. In short, 
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the findings highlighted the complexity of feeling states prior to genetic testing that often 
extended beyond the self to other family members. 
Reactions and Adjustment to Receipt of Test Results 
Studies that have investigated reactions to genetic testing seek to determine 
whether or not it causes significant psychological harm (Bleiker et al. , 2003; Braithwaite 
et al., 2006; Meiser, 2005). Particular attention has been given to measuring such 
cognitive and affective states as perceived health and risk for cancer, distress, anxiety 
depression, guilt, worry, fear of cancer/death, and intrusive and avoidant thoughts. Other 
areas of focus include such health outcomes as attitudes toward the future, psychological 
well-being, life satisfaction, and health-related quality of life (HRQOL). Significantly, 
limited research ex ists on evaluating the effectiveness of genetic counseling sessions fo r 
reducing the psychological sequelae surrounding genetic testing. Bleiker et al. (2003) 
noted that the positive impact of genetic counseling on decreasing psychological distress 
and enhancing risk perceptions remains unconfirmed. 
Despite consistent and favorable findings on psychological responses to testing, 
concerns ex ist about the reliability and validity of quantitative findings that rely on 
standardized measures (Coyle & Williams, 2000; McAllister et al. , 2007). everal 
authors emphasize the need for qualitative methodo logies to highl ight the scope of 
emotiona l effects in the short- and long-term, as well as theory generation to capture the 
psychosocial processes involved with genetic-based diseases (Bieiker et al. , 2003 ; 
Marteau & Weinman, 2006; McAllister, 2001 ; Riper, 2005). In fact, a couple of 
qualitative inquires have already provided new insights into the complexity and 
variability of emotional effects on individuals and families (Carlsson & Nil bert, 2007; 
McAllister et al., 2007). 
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McAllister's (2002) theory of engagement seeks to explain how the degree of 
engagement at the time of genetic testing influences reactions to test results. Engagement 
is proposed to be a continuous process that fluctuates over time and with the unfolding of 
family cancer-related events. McAllister (2002) conjectured that the process varies 
according to the blend of cognitive and emotional factors. For example, individuals who 
are intensely engaged appear to accept their carrier status more quickly, whereas those 
partially engaged experience some anxiety in the early post-test period. 
In a qualitative inquiry focusing on the psychological impact of predictive genetic 
testing for HNPCC, Reeve et al. (2000) found that the genetic testing event is viewed by 
many participants as a normal progression in ones' search for answers to what is 
happening or had happened to the family. Many of the study participants also commented 
upon the emotional benefits (i .e., level of protection provided by screening). Although 
distress was minimal , there were reports of worry and concern for the children, especially 
concerning their willingness to follow recommended screening protocols. 
In summary, although studies have consistently shown that anxiety and distress 
levels rise and fall over the course of the genetic testing period and appear manageable in 
the short-term, the qualitative evidence suggests that the depths of the emotional aspects 
to testing are not yet fully explored. The use of a knowledge sharing approach in genetic 
counseling practice may also be ignoring many of the emotional concerns of family 
members at risk. These findings give credence to the emerging evidence that awareness 
and experiential knowledge are key components of emotional readiness and reactions to 
testing for HNPCC. No doubt recent literature indicates the need to assess emotional 
readiness and possible reactions to genetic testing during pre-counseling sessions. 
However, the extent to which these findings have influenced practice remains unclear. 
Family Communications about Cancer Risk 
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Another key factor in the genetic testing process is the role of family 
communications. ommunications in families about HNPCC and genetic testing are just 
beginning to be understood (Gaff et al. , 2005; Koehly et al. , 2003 ; Mesters et al. , 2005; 
Peterson et a l. , 2003). Many of the studies are qualitative and de criptive in nature and 
employ the use of semi- tructured interviews. ome of these stud ies have explored 
communication patterns, motivations about disclosure, and/or reactions of family 
members to information on HNPCC and genetic testing (Gaff et al., 2005 ; Mesters et al. , 
2005; Peterson et al. , 2003). 
The importance of communication within fam ilies about HNPCC and genetic 
testing cannot be understated. In most cases, the proband, or first person in the family 
recognized as being at risk by the health care y tem, carrie the burden of in fo rming 
other family members about HNPCC and genetic testing. Difficul t family relationshi ps, 
fear of potential rejection and protective factors , such as the unwillingne s to alarm oth r 
may hinder the communication process and prevent family member from disclosing 
information about HNPCC and genetic testing. Non-disclosure has the potential to place 
family members at an increased risk for HNPCC when they could be fo llowing 
recommended screening protocols (Koehly et al. , 2003). 
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Study findings demonstrate that information about the identification of an 
HNPCC gene mutation is most often perceived as a private family matter and not 
something to be openly announced to others. Communications about the genetic risk for 
disease are occurring either within the immediate family or with select extended family 
members (Gaff et al., 2005; Mesters et al. , 2005; Peterson et al. , 2003). Both women and 
men report telling children and their siblings about their HNPCC genetic testing result 
within the first 48 hours of testing. If the children are considered to be too young, many 
are choosing to postpone discussions until they are older (Gaff et al. , 2005 ; Mesters et al. , 
2005; Peterson et al. , 2003). 
Only a few individuals report that they told extended family members about their 
results in the immediate post-test period. In many cases, it takes years to inform all 
family members across generations. The challenge here is that the information about risk 
and cancer status among multiple fami ly members is constantly changing and therefore 
communication on the matter is an ongoing process (Gaff et al. , 2005 ; Mesters et al. , 
2005; Peterson et al. , 2003). 
Motivations for disclosure amongst family members include moral obligation and 
anticipatory regret. Study findings indicate that disrupted and tense family relations 
impede disclosure. Importantly, if individuals experience negative reactions on their first 
attempt to inform others about the genetic link, they tend to be reticent about doing so 
again (Gaff et al. , 2005; Mesters et al. , 2005). 
Van Oostrom et al. (2006a) reported changes in second-degree relationships in 
their study on family impacts. Carriers and non-carriers reported difficulty talking about 
hereditary cancer and emotional distance. Commentary on the context of difficult 
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situations or conflicts with respect to genetic testing include differences in attitudes 
towards testing (i.e., those engaging versus declining) and the tendency of certain family 
members to impose secrecy on the topic, both within and outside the family network. 
Moreover, the presence of external cues is an important factor influencing 
disclosure among family members. If health care professionals verbally stressed the 
importance of communicating this information, it surfaced as an important motivator to 
get the word out to other family members. Also the number of fatal cancers in the family 
emerged as being a very relevant motivator for disseminating news ofHNPCC and 
genetic testing (Gaff et al., 2005; Mesters et al., 2005 ; Peterson et al. , 2003). 
Carlsson and Nilbert's (2007) study also revealed important themes on 
communications within fan1ilies. All participants discussed the importance of 
understanding and conveying information about the results. Once they became aware of 
the hereditary cancer risk, they expressed a desire to advocate, support and engage other 
family members to seek information and become involved with screening surveillance 
progran1s. Nevertheless, many participants expressed difficulty knowing what to do with 
relatives with whom they have had very little contact. As well , some participants were 
concerned about telling others if they felt ill-equipped to deal with different reactions to 
the news. In some instances, old disputes and new aggressions arose when the hereditary 
cancer was confirmed, whereas in other situations relationships improved. 
Summary 
The findings from earlier studies suggest that emotional experiences immediately 
prior and in the hort-term following testing are manageable. However, the re liability of 
many of these studies has been questioned. More recent studies have found that the 
emotional experience of genetic testing for HNPCC is a broad and more intense 
experience that extends backward in time to the years prior to testing. Dealing with 
cancer illness in close family members and coping with multiple family losses have 
important implications for readiness for genetic testing and reactions and adj ustment to 
test results in the short- and long-term. 
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Other studies suggest that those more aware of the cancer hereditary link and/or 
those with more difficult memories associated with cancer in the fam ily have little 
difficulty making the decision to test. In some instances they are more prepared (Reeve et 
al. , 2000). Meiser's (2005) review of 15 tudi es on participants testing for hereditary 
cancer confirmed this finding. The review concluded that those who had personal and 
famil y experi ences with cancer are more likely to undergo genetic tes ting than those who 
decline. Hereditary cancer awareness and experiences in the years prior to testing appear 
to have signifi cant import fo r the process, as do risk perceptions and coping strategies. 
Communication within families about HNPCC and genetic testing is an essentia l 
consideration for genetic counseling services. Most often the burden rests w ith a carrier 
affected by the disease. C learly the fam ily dynamics and personal relationships have the 
potential to interfere with timely communication of info rmation putting family members 
at risk. How best to support the individual who becomes the designated communicato r 
still needs to be determined. 
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The Post-Test Period 
The post-test period refers to long-term adjustment following confirmation of a 
carrier or non-carrier status for HNPCC. For most, the period is marked by struggling to 
cope with personal and family issues, and adhering to recommended screening protocols 
and follow-up when abnormalities are detected. Studies exploring adjustment are largely 
quantitative and focus on the personal psychological and behavioural impacts shortly 
after genetic testing. Significant gaps ex ist in this literature, including personal and 
family challenges over time, the support and information mechanisms needed by carriers 
and their families to buffer these challenges, and how experiences with the health care 
system can facilitate or impede effective disease management. 
Psychosocial and Emotional Adjustment 
Meta analyses and literature reviews indicate that there is minimal psychological 
harm associated with undergoing genetic testing for HNPCC. Prospective studies suggest 
that distress levels rise slightly for carriers immediately in the post-test period and return 
to baseline levels within a year, but decrease immediately for non-carriers and remain 
relatively stable during the follow-up period (Aktan-Collan et al. , 200 I; Claes et al. , 
2004; Claes et al. , 2005; Murakami et al. , 2004). Despite these positive results, there are 
reliabi lity and validity concerns around the use of single items to measure psychological 
outcomes of genetic testing (e.g., depression, anxiety, distress, cancer worry, etc.) and 
few of the standardized instruments measuring outcomes have been validated in 
populations with genetic-based diseases (Bleiker et al. , 2003 ; Braithwaite et al. , 2006; 
Broadstock et al. , 2000; Heshka et al., 2008; Meiser, 2005 ; van Ostroom, 2006a, 2006b). 
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The following review is divided into two major sections. First, quantitative and 
qualitative study findings from HNPCC populations are discussed. Second, a discussion 
is presented on recent theoretical/conceptual models for guiding research inquiries that 
focus on long-term adjustment of individuals and families with genetic-based diseases. 
Descriptive findings. Heshka et al. (2008) reviewed 30 randomized control trials 
and prospective studies on the perceived risks, and psychological and behavioural 
impacts of genetic testing for hereditary disease. For the majority of studies, the 
perceived risk of HNPCC in carriers was lower one year after testing compared to pretest 
levels. Furthermore, no overall differences were detected in outcomes evaluated (i.e. , 
general distress, anxiety, depression, and disease specific woiTy) between carriers and 
non-carriers. Finally, most study findings failed to detect any of the anticipated negative 
psychological outcomes. 
Several authors noted that there is limited empirical evidence to make any definite 
conclusions about long-term psychosocial effects (d' Agincourt-Canning, 2005; Bleiker 
et al. , 2003; Braithwaite eta!., 2006; Heshka et al. , 2008; Kenen et al. , 2003; Mei er, 
2005). Bleiker et al.'s (2003) review article on risk perceptions after testing suggests that 
knowledge of an increased probability of developing a life-threatening condition long 
before its onset can be quite burdensome, given that the options for managing risk are 
currently limited. This review also noted that there is a significant amount of speculation 
about the existence of survivor guilt among those who do not carry the gene mutation. 
The findings suggest that non-carriers report feeling guilty about receiving good news 
and inadequate about he lping others in the family who are dealing with a carrier status 
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and/or cancer onset. Hence, the psychosocial impacts apply to both carriers and non-
earners. 
The findings from qualitative studies suggest that there is a range of complex 
concerns not being considered regarding overall psychological adjustment to a canier 
status. Major influencing factors include differences in personal understandings of 
perce ived risk and coping ability with respect to maintaining a positive mindset and 
feeling in control of the disease. Researchers concur that experiential knowledge and 
development of ri sk perceptions related to living with heredi tary cancer and individua l 
coping strategies are all important factors post-genetic testing. How these factors relate to 
one another and respond to the evolution of events during the years preced ing testing 
becomes increasingly relevant for psychosocial and emotional well-being following 
genetic testing for HNPCC. Finally, more information is required about how risk 
perceptions fo r future disease states influence acceptance of and adjustment to genetic 
test results in the short- and long-term (d' Agincourt-Canning, 2005; Kenen et al. , 2003; 
McAllister, 200 I , 2002). 
Several studies have been designed to explore potential factors that may moderate 
the distress levels of individuals post-genetic testing. Although distress levels tend to fa ll 
within healthy ranges fo r HNPCC carriers, van Oostrom et al. (2006b) fo und that the 
familial contex t had a significant effect. Specifically, individuals who had a parent 
affected by cancer at a young age and were exposed to a greater number of fi rst-degree 
relati ves affected by cancer tended to evidence higher levels of distress fo llowing genetic 
testing. Similar findings have been reported by other researchers (Erblich, Bovbjerg, & 
Valdimarsdotti r, 2000; Esplen et al. , 2003). 
30 
In a recent prospective study covering a one year period, Shiloh, Koehly, Jenkins, 
Martin, & Hadley (2008) investigated the distress levels of individuals classified as high 
monitors (i.e., hyper vigilant over potential health threats and active information-seekers 
about ways to buffer them). These authors found that high monitors evidenced more 
distress in the pre-test period and upon receiving indeterminate or positive results about 
their HNPCC canier status. The researchers also cautioned that high monitors generally 
experience greater distress in response to critical events that threaten their well-being. 
That is, individuals who fall into this group tend to perceive greater personal risks and 
experience more intrusive ideation and encode events as catastrophic. On the positive 
side, high monitors may also experience greater emotional benefits from genetic testing 
(i .e., high monitors tend to be more positive about their ability to control their cancer risk 
if they adhere to recommended screening protocols). Importantly, levels of distress and 
depression diminished over time and appeared to be a function of elevat d levels prior to 
genetic testing. 
Besides the individual, genetic testing for HNPCC impacts the total family 
system. Mcinerney-Leo (2005) examined changes in cohesion, expressiveness and 
conflict in close family relationships with individuals undergoing genetic testing. Most 
study participants felt that family relationships became closer due to the genetic testing 
process. In contrast, two Belgian studies by Claes et al. (2004) and Claes et al. (2005) 
evaluated the impacts of genetic testing on family relationships in samples of carriers and 
non-carriers. Study findings revealed a large variation between carriers' and non-carriers ' 
perceptions. Only a very small percent of non-carriers (6%) reported negative changes in 
partner relationships, whereas a significant proportion of carriers ( 40%) reported a 
negative change in relationships with their children. 
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van Oostrom et al. 's (2006a) prospective study evaluated the psychological 
impact of genetic testing on the entire fami ly unit. Significantly, HNPCC carriers 
reported more positive changes in famil y relations than non-carriers. Many of the carriers 
reported feeling closer to partners and siblings, improved relations with chi ldren, greater 
understanding and support from parents, and improved communication towards second 
degree relatives. A smaller number of carriers reported negative relationship changes, 
including greater emotional distance, guilt feelings about having passed on the mutation 
to their children, secrecy, strained communication around hereditary cancer or genetic 
testing, and diminished support. In the final analysis, fami lies rated as "enmeshed-
chaotic" or "disengaged- rigid" at baseline reported more adverse consequences in 
relationships. Participants who felt constrained in communicating about the hereditary 
cancer and less supported at baseline reported more frequent adverse effects on 
relationships and greater family difficulties in the post-test period. 
van Oostrom et al. (2003) conducted a long-term follow-up study of female 
carriers and non-carriers tested for hereditary breast/ovarian cancer. Although no 
s ignificant differences were detected between carriers and non-carriers on distress and 
cancer worry one and five years after genetic testing, both groups showed a significant 
decrease in anx iety and depression at the one year mark, but a steady increase in these 
levels at the five year follow-up. The most ignificant predictor of long-term cancer-
re lated distress and cancer worry was hereditary cancer-related distress at baseline or pre-
test disclosure. The second most significant predictor for targeted outcomes at five years 
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follow-up varied. Having children less than 15 years of age at baseline was predictive of 
cancer-related distress, and knowing one or more relatives who died of breast and/ ovarian 
cancer was predictive of cancer worry. Long-term distress and cancer-specific worry was 
also associated with less open family communications about the test result and more 
doubts about the validity of test findings. In contrast, changes in relationships with 
relatives emerged as a significant predictor of distress, whereas greater perceived risk of 
breast cancer was a s ignificant predictor of worry (van Oostrom et a l. , 2003). 
In a later tudy offan1ilies with BR I /2 and/or HNPCC, van Oo trom et a l. 
(2007) explored s ignificant predictors of hereditary cancer-related distress. During 
regression analysis the most significant predictor of distress was pre-test distress levels. 
Other predictors in the model were complicated grief or unresolved lo ses, number of 
first-degree relatives affected, more intense emotional representat ion and non-carrier 
status. The author concluded that individuals who have clinical levels of distress at 
baseline seem to be more in need of psychological supp01i in the short- and long-term. 
Theoretical insights. One of the most significant gaps in the literature on the 
long-term impact of genetic testing is the absence of a well-developed conceptual/ 
theoretical base to guide research inquirie in thi s area (Biesecker & Erby, 2008; 
McAllister et al. , 2008a; Rolland & Williams, 2005). Using a grounded theory design, 
McAllister et al. (2008a) proposed a framework for exploring patients continued need for 
genetic service after testing to maintain the benefi ts associated with going through the 
process. Empowerment was the overarching theme. Empowerment was defined as a 
belief system that allowed a person to take control of their li ves and feel responsibility for 
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their decisions in the post-test phase. Individuals felt that genetic testing allowed them to 
make life decisions in an informed way and gave them sufficient information about the 
condition, including risks to the self and other family members. It helped them make 
effective use of the health care system, gave them the ability to look to the future and fee l 
hope for a fulfilling life. This study identifies the importance of feeling in control of the 
disease, a desire for hope for the future, the need for accurate risk information and the 
role of the health care system. 
A frequently identified problem is the conceptual ambiguity around the full 
meaning of adaptation for individuals with a confirmed HNPCC gene mutation, as well 
as their families. One relatively recent attempt to reduce this gap is the work by Biesecker 
and E rby (2008). The authors highlighted that an individual's adaptation to a genetic test 
result has typically been studied as a finite outcome. This approach is valid provided 
relevant observable indicators can be identified. More importantly, adaptation may be 
viewed as an evolving process such that at any one point in time an individual can be 
assessed as be ing more or less adjusted. This view highlights the reali ty of the ups and 
downs associated with a persistent personal and/or family cancer threat. In keeping with 
these two approaches, the authors suggest there is a clear need for a multidimensional 
outcome measure capable of assessing levels of adaptation to living with a genetic 
condition at a given time point. Such a measure should incorporate intrapersonal and 
interpersonal outcomes of the process and include cognitive and emotional responses to 
having HNPCC. 
Another attempt to recti fy this conceptual gap is the work by Rolland and 
Wi lliams (2005). The authors propose a biopsychosocial model that highl ights some of 
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the developmental challenges associated with having a genetic condition that has a high 
probability for cancer onset. This model provides a useful framework to guide inquiries 
into potential issues/challenges confronting individuals as they move from the pre-
symptomatic phase through disease onset through treatment modalities and follow-up. 
One study was identified that relied on the Rolland and William's (2005) 
developmental model to examine adaption over a four year period in a sample of 
individuals tested for hereditary breast and ovarian cancer. Hamilton, Williams, Skirton, 
and Bowers (2009) uncovered four concepts in the long-term adaptation phase of living 
with genetic knowledge over time. Participants acknowledged the strain imposed on 
family relationships after testing and what individual members did to try and counteract 
it. Some participants spoke about becoming empowered as a result of knowing their 
carrier status (e.g., increasing screening, seeking support and education, and considering 
or acting upon prophylactic measures to offset risk). Other participants became more 
uncertain and developed a sense of mistrust over their bodies. Participants also made 
conscious choices to adopt healthy lifestyle habits and gather further knowledge about the 
condition and related screening. Many felt a positive aura, a new lease on life and luckier 
than other family members who did not have thi s opportunity and had already succumbed 
to the disease. Finally, adjustment in the long-term also meant dealing with concerns for 
the next generation, as mothers described struggles with what to tell offspring and how 
and when to tell it. Importantly, adjustment was defined by personal and family impacts 
over time and was marked by the need for support and fo llow-up. 
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Behavioural Adjustment 
Only a limited number of studies have identified behavioral adjustment in the 
post-genetic testing phase as an important area for research inquiry (Braithwaite et al., 
2006; Bleiker et al. 2003; Heshka et al. , 2008; Meiser, 2005). In addition, most of this 
research tends to be quantitative and more concerned about screening adherence rates 
than barriers to and/or facilitators of timely access to screening tests and follow-through 
from diagnostic testing to treatment and ongoing surveillance. There is a growing body of 
qualitative evidence which suggests that health care in itself can be a significant barrier to 
individual and family willingness to follow recommended protocols for HNPCC. Specific 
reference has been made to such things as ineffectual co-ordination, non-person centered 
care, limited provider knowledge and expertise, and inadequate provider/clinician 
communication skills, among others. 
The few research studies that have focused on the behavioural aspects of 
adjustment to genetic testing provide insight into screening recommendations, adherence 
rates, and patient preferences for support in helping with disease management (Bieiker et 
al., 2003 ; Braithwaite et al. , 2006; Etchegary, 2004; Heshka et al. , 2008; Marteau & 
Weinman, 2006; Meiser, 2005; Vasen, 2007). Although most study findings suggest that 
carriers regularly engage in screening protocols to identify early HNPCC cancer onset, 
the evidence is less clear on the exact scope of these protocols and the frequency intervals 
between screening procedures (Heshka et al., 2008; Lindor et al., 2006; Lynch et al. , 
2008; Schmeler et al., 2006; Schroy, Glick, Robinson, & Heeren, 2007; Vasen, 2007). 
More importantly, there is limited insight into potential barriers to regular screening (e.g., 
personal, informational , logistical, and health care system-related barriers). 
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It is well-documented that regular colonoscopy surveillance leads to the detection 
of cancer in its early stages and results in an overall positive impact on survival for 
HNPCC carriers (Dove-Edwin, Sasieni, Adams, & Thomas, 2006; Green et al., 2002; 
Jarvinen et al., 2000; Pylvanainen, Kairaluoma & Mecklin, 2006; Stuckless et al. , 2007). 
Despite these positive findings concerning the impact of regular screening on morbidity 
and mortality, there continues to be controversy over the age of initiation and time 
intervals between colonoscopy and the scope and frequency of extra colonic screening for 
effective HNPCC management (Lindor et al., 2006; Lynch et a l. , 2008; Schroy et al. , 
2007; Vasen, 2007). 
Lindor et a!. ' s (2006) systematic review explored the recommendations regarding 
HNPCC cancer screening and prevention during the past decade. Current evidence fu lly 
supports colonoscopy for carriers every one to two years beginning at age 20-25 and 
annual endometrial sampling through trans-vaginal ultrasound of the uterus and ovaries 
starting at age 30-35. In addition, because of the excess oftransitional cell carcinoma of 
the uro-epithelial tract, urinalysi s and cytology must be ini tiated between 25-35 years of 
age. For those who develop CRC a subtotal colectomy is favoured . 
There are also reports of the efficacy of prophylactic hysterectomy and 
oophorectomy for HNPCC carriers. Defining an optimal screening regime for HNPCC 
remains a challenge as the types, frequency and age of screening initiation vary according 
to family history, age of onset, number of fami ly members affected and the mutation 
involved (Lindor et al., 2006; Lynch et al. , 2008). 
Research conducted on compliance and predictors of creening behaviour fo r 
CRC patients, highlights that physical di scomfort may act as a deterrent to adhering to 
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necessary screening regimes. Several authors also suggest that emotional consequences, 
such as concerns about the effectiveness of screening protocols, and fear of negative 
findings, and the cumulative effect of having so many of these tests over time need to be 
considered as real barriers to maintaining screening regimes (Beeker, Kraft, Southwell, & 
Jorgesen, 2000; Neilson & Whynes, 1995; Pylvanainen et al., 2006). 
Study findings also indicate that individuals and families are in need of system 
and provider supports to facilitate adherence to screening protocols and disease 
management over time (Geary et al. , 2007; Lindor et al., 2006; Lynch et al. , 2008). 
HNPCC fam ilies require ongoing health care supports, not only to facilitate adherence to 
screening regimes, but to support the ongoing challenges posed by cancer onset, new 
information and ongoing testing of other fami ly members (Griffin et a l. , 2007; McAllister 
et al. , 2008b). In a recent qualitative study, McAllister et al. (2008b) identified five areas 
that patients and health care providers deem imp011ant for long-term clinical genetic 
services. Participants wanted local and accessible services, open access and follow-up, 
coordinated, tailored fami ly care, a quality patient-clinician relationship, and time to ta lk. 
Effective support requires knowledgeable physicians and genetic counselors, educated 
patients, and readily avai lable clinical cancer genetics services (Lindo r et al. , 2006; 
Lynch et al. , 2008). 
Oftentimes individuals at risk for CRC receive insuffic ient and inconsistent 
information on the timing and expectations of screening, yet there needs to be an 
established flow of up-to-date screening and treatment protocols for HNPCC (Hadley et 
al. , 2003 ; Lynch et al. , 2008). Study findings indicate that primary care physicians, 
specia lists, genetics personnel and other health care providers have an important role to 
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play in improving and sustaining adherence to screening in those at risk for HNPCC 
(Lindor et al., 2006; Lynch et al., 2008; McAllister et al., 2008b; Stermer, Hodgson, & 
Kavalier, 2004). A multidisciplinary approach to HNPCC has been suggested (Geary et 
al., 2007). 
The reality of maintaining comprehensive screening practices over time in 
accordance with updated guidelines may be more of a challenge than is known and needs 
further examination (Braithwaite et al., 2006; Collins, Meiser, Ukoumunne, Gaff, St. 
John, & Halliday, 2007; van Oostrom et al. , 2006a). More specifically, the value and 
importance of follow-up of carriers and non-carriers during the adj ustment phase by 
clinical genetics is apparent in the literature. 
Summary 
Overall, the empirical evidence from quantitative studies demonstrates that there 
are minimal psychosocial and behavioural effects from genetic testing in the shoJi -term. 
The presence of a comparable database on the long-term psychosocial effects for both 
carriers and non-carriers ofHNPCC is quite limited. Importantly, adjustment after testing 
has been viewed as an ongoing process occurring on personal and fam ily levels. 
Consideration may need to be given to past coping styles and experiences with cancer 
illness and loss in the family, as the impact that these factors have on the acceptance of 
and adjustment to one's test results have yet to be fu lly realized. 
Research findings also identify the impact testing has on the larger fami ly system 
in some instances making relationships more cohesive and in others causing significant 
strain. New theoretical insights conjecture that adjustment should also be viewed as an 
..---------------------------------------- ---
ongoing process that takes place over time in the face of the constant cancer threat. 
Models highlight the importance of developmental challenges and fan1ily system 
approaches to guide inquiries exploring adjustment over the long-term. 
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The need for ongoing support has been recognized to help those tested to adhere 
to extensive, ever-changing and lifelong screening regimes for effective disease 
management and to assist other fan1ily members to embrace and act on the new 
knowledge. Primary care physicians, specialists, genetics personnel and other health care 
providers have an important role to play in facilitating and helping sustain adherence to 
screening. HNPCC familial cancer registries and family information services are believed 
to be effective mechanisms for facilitating ongoing communication with individuals and 
families at risk for this syndrome. 
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CHAPTER3 
Methodology 
The focus of this chapter is on describing the qualitative methodology used in the 
cunent study to explore the psychosocial processes emerging from exon 8 deletion family 
members' descriptions of how they were experiencing HNPCC in the ir families. The 
original study used grounded theory methodology to: (1 ) explore the meaning of 
predi ctive DNA testing for individuals in families at risk for developing colorectal cancer 
and related-cancers due to intron 5 splice site mutation on exon 5 or deletions on exon 8, 
and (2) develop a greater understanding of the psychosocial and behavioral impact of 
genetic testing on individuals who were confirmed carriers or non-carriers of HNPCC. 
The current study was an extension of the larger qualitative study and, thus, used a 
modified grounded theory methodology. 
Research Design 
The fo llowing section describes the methodology used to guide the inquiry into 
the problem under focus in the current study. lt might be helpful for the reader if a brief 
description was provided of grounded theory versus modified grounded theory. 
Grounded Theory as Method 
Grounded theory methodology provides a highly systematic method of analyz ing, 
interp reting, and categorizing qualitative interview data into substantive socia l theory 
about the dominant socia l processes of a g iven phenomenon (Streube rt Speziale & 
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Carpenter, 2003). Glaser and Strauss (1967) are credited with the original development of 
grounded theory methodology. Based on the principles of symbolic interactionism, a 
grounded theory approach proposes that how individuals and families respond to an event 
is related to their existing meaning structures. Exploring how the event is processed on a 
cognitive, emotional, and behavioural level, within these existing meaning structures, 
helps reveal coping and adj ustment strategies used over time (Chenitz & Swanson, 1986; 
Glaser & Strauss, 1967). 
Grounded theory functions under the principles of induction, commonality, and 
conceptualization which are maintained by its key feature- the constant comparative 
method of analysis. This method requires a simultaneous data collection, coding, and 
analysis within and across interview data to reveal theoretical categories, properties and 
descriptors and the conceptualization of social theory. Substantive coding and memoing, 
which uses words of the interviewees themselves, further coiToborates findings. 
Theoretical and purposive san1pling faci li tates the representativeness of the data and 
ensures that there is a relevant range of experience. According to Glaser and Strauss 
(1967), rigor is enhanced as the information pertinent to the emerging theory comes 
directly from the data. Therefore, the theory generated is grounded in the data. 
Researchers increasingly employ the use of qualitative data to ubstantiate health 
experiences, as it is provides the richest evidence fo r planning health care (Gi lgun, 1992; 
Morse, 1994). Many interested in understanding and explaining the experience of genetic 
testing for HNPCC have used quali tative research, with some using grounded theory as a 
means to build substantive theory directly from the experiences of fami ly members who 
have undergone the process (McAllister, 200 I). The main advantage of this method is 
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that the resulting theory and its various hypotheses can be empirically tested and used to 
aptly guide clinical practice in the area of cancer genetics. 
Modified Grounded Theory 
A modified grounded theory approach to data collection was chosen for stage 2 of 
the larger qualitative study. The decision to use a modified as opposed to a pure approach 
was dictated by the emergent questions that seemed to be unanswered by the origina l 
study. Thus, the focus of the CUITent study was on expanding the theoretical and empirical 
base on how personal understandings of hereditary based cancer and situational and 
contextual factors influence an individual's decision-making. In the original qualitative 
study (stage 1), the primary focus of data collection was on the purposive selection of 
individuals from fam ilies with the intron 5 splice site mutation on exon 5, with a lesser 
emphasis on individuals in families with exon 8 deletion. The rationale for this was the 
presence of a larger pool of potentia l participants from fami lies with the intron 5 splice 
site mutation on exon 5. As the original study drew to a close, the research team 
questioned the importance of time since the discovery of the family-based gene mutation 
and the family context, especially relations and supportive structures. 
For the current study, there was a deliberate selection of individuals from 
famil ies with the exon 8 deletion. As well , the theoretical sampling logic used in the fina l 
stages of the original qua litative study meant that greater attention needed to be placed on 
family clusters of carTiers and-non-carriers of HNPCC, and carriers with and without 
cancer. The specifics of the participant recruitment are detailed in a subsequent section. 
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Predictive Genetic Testing 
Predictive DNA testing is offered to individuals with a family history of CRC 
who are referred to the cancer genetics service by family physicians or specialists 
(gastroenterologist, surgeon or oncologist). All exon 8 deletion participants were first 
assessed by a geneticist or genetic counselor to be at high risk for HNPCC based on the 
Amsterdan1 I and II and/or Bethesda criteria (Merg, Lynch, Lynch, & Howe, 2005). That 
is, participants who were deemed to be 50% risk for inheriting the MSH2 mutation were 
entered into a counseling program to prepare them for predictive DNA testing. 
Once participants were informed of their risk individually or during family 
sessions, a fo llow-up counseling session was held with them to determine their interest in 
undergoing genetic testing for HNPCC. In addition to being counseled on the benefits 
and risks associated with genetic testing for HNPCC, participants are reminded of the 
known implications of can·ier status, such as more frequent and extensive screening for 
the self, increased risk for offspring as well as insurance and psychosocial effects. As all 
study participants opted for testing, blood samples were collected and forwarded to a 
clinical molecular genetics lab for analysis. 
Following genetic testing, carrier or non-carrier results were reported in face-to-
face individual/family counseling sessions. In most cases, a supportive person was 
present. A fo llow-up letter summariz ing the results of the counseling session was sent to 
the participants and their physicians. Clinical screening programs were adjusted 
according to the results. Genetic testing was also offered to the probands children and 
siblings who had reached the age of maturity (i.e. , 18 years of age). 
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Population and Participant Recruitment 
The target population for the initial quantitative survey was restricted to 
individuals from high risk families registered in the Medical Genetics Program of 
Newfoundland, who had DNA testing for HNPCC and had received or were waiting for 
test results. The eligible population consisted of carriers and non-carriers from families 
with a confirmed MSI-12 mutation on intron 5 (12 families) and exon 8 (5 families) 
(Stuckless et al., 2007). With the exon 8 mutation identified more recently (early 2000's) 
than the intron 5 mutation (early 1990's), there was a larger cohort avai lable from the 
latter group for research purposes when data collection commenced in 2004. 
A total of276 individuals were identified for possible contact (i.e., exclusion of 
presumed positives, obligate carriers and unknowns). From this group, 75 individuals 
could not be contacted (i.e., 46 due to incomplete information and 29 unable to reach 
after multiple attempts). Contact was subsequently made with 20 I individuals; 188 of 
whom agreed to receive study materials. Of the original consenting group, 120 returned 
completed questionnaires and s igned consent forms (see F igure I). 
Data collection for the original qualitative study occurred from late 2004 to the 
early 2007. For this study, a purposive sample was derived from the 120 respondents to 
the quantitative survey who indicated an interest in further research. In this case, 
purposive sampling refers to the selection of individuals known to this researcher from 
the earlie r quantitative study and con idered to be good informants. Theoretical sampling 
indicated that common themes were emerging after completion of 18 interviews and first-
level cod ing ( i.e., ub tantive code ). Interviewing was temporarily stopped and the 
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constant-comparative method of analysis applied to the data sets. A family meaning 
context (i.e., shared/different experiences and/or reactions and similar/variant timelines) 
emerged during the in-depth analysis and coding of the first 18 transcripts. In addition, 
meaningful differences were emerging between carriers and non-carriers of HNPCC (i.e., 
perception of screening protocols and time to cancer diagnosis, variant coping 
mechanisms, implications for children) and those affected and unaffected with cancer 
(i.e., intensity of reactions, burdensome versus sense of resilience). As a result of these 
insights, the foci shifted to purposive selection of an additional 14 HNPCC carriers from 
fan1ily pedigrees with and without a cancer diagnosis (see F igure 1). 
In the original qualitative study, five of the thirty-two participants had been tested 
for the exon 8 deletion mutation. Importantly, late in the qualitative analysis, length of 
time s ince the discovery of the family-based gene mutation for HNPCC and the 
availability of and actual involvement in genetic testing appeared to have significant 
impacts on individual and family perceptions of the experience. The importance of family 
context and meaningful differences between carriers and non-carriers and carriers 
affected and unaffected by cancer had emerged in the original study. Thus, purposive 
sampling was used to ensure equal representation of individuals fro m these groups. From 
earl y to late 2007, an additional seven individua ls were recruited from the exon 8 deletion 
families. 
Figure 1. Flow Chart of Sampling Plan 
Eligible (N = 276) 
Contacted (N = 201) 
Agreed (N = 188) 
1 
Returned urvey (N = 120) 
Quantitative Survey 
1 
Original Qualitative (N= 32) 
intron 5 (6/12 families): n=27 
exon 8 (2/5 familie ): n=5 
Total Qualitative Sample (N=39) 
intron 5 (6/12 families) 
exon 8 (3/5 families) 
Unable to Contact (N= 75) 
46 (incomplete information) 
Refused (N = 13) 
Additional Exon 8 (n=7) 
exon 8 (2/5 families) 
l 
Total Exon 8 (N = 12) 
exon 8 (3/5 families) 
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The final sample consisted of three family groupings of four individuals - six 
carriers, six non-carriers; four affected and eight unaffected. The large volume of 
narrative data generated by the 12 exon 8 deletion family participants was sufficient to 
represent the experiences of those more recently tested for HNPCC and did not alter 
existing categories (Sandelowski, 1995). Thus, a final sample of 12 participants from 
families with the exon 8 deletion mutation was used to augment and confirm the 
proposed model. 
Procedure 
Potential participants from exon 8 deletion families were identified by the 
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research team from the same population eligible for the original study. Due to the 
psychosocial nature of the research and related risks, those with a known previous 
diagnosis of anxiety, depression, mental illness or substance abuse were excluded. Those 
who had previously been involved in quantitative research in this area and had indicated a 
willingness to be involved in further research were first contacted by phone to ascertain 
whether or not they were willing to receive a package of information on the study. 
Information packages included a cover letter and a brief summary of the study (see 
Appendix A), and two copies of the consent form (see Appendix B). Individuals who 
required further information on the study were encouraged to contact the researcher either 
through local or toll free numbers. Subsequent contact was made within two weeks of the 
mail out to ascertain patients' willingness to be interviewed. Interviews were scheduled at 
a mutually agreed upon time. 
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Interview Schedule 
Informed, written consent was obtained prior to the first interview and 
participants were asked for their permission to be audio-taped. In-depth, semi-structured 
interviews were conducted using the interview schedule designed fo r the qualitative study 
(see Appendix C). Although the schedule items were used to guide the interview process, 
additional questions generated by the ongoing data analysis were also integrated into 
subsequent interviews. After analysis of the fi rst two interviews, major content areas 
were identified to further guide the interview process. For example, participants 
highlighted the struggle to deal with losses, the prolonged impact it had on them and 
close family members, and their search for greater meaning, understandi ng, and certainty. 
The rich descriptions of experiences that led them to the possibil ity of a cancer genetic 
link were subsequently used as probes fo r interviewing additional participants. 
The initial interviews also provided detailed descri ptions about the impact of the 
genetic testing experience and adj ustment challenges for both carriers and non-carriers. 
For example, some of the non-carriers portrayed the genetic testing experience as a non-
event and described a healthy adj ustment to learning their HNPCC risk status, while 
some carriers fe lt shock and disbelief. These variat ions in descriptions that occurred 
according to carrier status were noted and teased out during subsequent interviews. T he 
second interview took place approximately six months after the first to provide 
participants with a summary of thei r interview and to obtain feedback on its 
interpretation. 
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Ethical Considerations 
Approval to conduct the proposed research study was granted from the Human 
Investigation Committee (HIC), Memorial University ofNewfoundland (see Appendix 
D). Ethical considerations for participants and the data generated were clearly identified 
and discussed during the consent procedure. 
Participants were interviewed in the place most convenient for them and their 
privacy was ensured. During the first interview, participants were made aware of the 
potential risks and benefits of participating in the study. They were a lso given the choice 
ofterminating the interview. However, this option was not utilized by any of the 
participants. Given the personal and sensitive nature of cancer and genetic information, 
there was an additional consideration for the protection of privacy and confidentiality of 
specific genetic test results and cancer episodes among fami ly members during the 
interview process. 
Participants were infotmed that all information collected would be described in a 
manner that would prevent identification of the source. Also, no direct benefits were 
anticipated and they were free to withdraw from the study at any time without having to 
give a reason, nor would their participation affect any future aspect of care. 
Appropriate measures were taken to ensure that the confidentiality of all data was 
maintained. All tapes and transcriptions were coded and kept in a locked location. A 
database of names and matching codes was also stored under password protection 
accessible only to this researcher. The tapes and transcriptions will be maintained until 
the final publication phase of this study and subsequently destroyed five years fo llowing 
this phase. 
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Data Analysis 
Data analysis proceeded in several phases with the constant-comparative method 
of ana lysis being integrated in the process. Taped interviews were transcribed verbatim, 
checked for accuracy and then perused independently by the two member research team. 
The focus was on interpreting the meaning of words and sentences through reading and 
rereading of each transcript. Beginning after the first interview, the researcher and thesis 
supervisor independently coded the lines of the transcripts as appropriate, according to 
the substantive coding and themes established by the original conceptualization. This 
served two purposes. First, it allowed the researchers to become immersed in each 
narrative and to construct interpretive summaries. Second, it helped to identify further 
probes and questions. Regular debriefing sessions were he ld to compare independent 
transcript coding and achieve consensus on the identity of the constructs and properties. 
Additionally, each transcript was perused for major thematic content related to the 
major constructs already developed in the original model. Challenges posed fo r 
individuals and their fami lies at different time periods (i.e., pre, during and post-genetic 
testing) were also identified. This information was also used to construct interpretive 
summaries. Valid ity was assured by having two researchers construct independent 
interpretive summaries of each transcript and achieve consensus on the final versions. 
Partic ipants were given an opportunity to read, or receive a verbal presentation on their 
interpretive summaries. All participants confirmed their interpretive summaries, adding a 
further element of credibility to the findings. 
All. lines of each participant transcript were then reinterpreted and built as in the 
origina l study in the form of a family narrative, which fac il itated further comparisons 
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between the original family groupings and new ones. Differences were confirmed 
between carriers and non-carriers as well as those affected and unaffected with cancer in 
accordance with intensity of reactions, length of exposure and burden versus resilience. 
The importance of time since testing to the length of the awareness period and its 
significant impact on the process was established by exon 8 deletion participants. Views 
on screening protocols, timelines to diagnosis, short- and long-term coping mechanisms 
and implications for children were also confirmed by this new data. 
In addition to the validity and reliability features of this work, other qualitative 
principles were maintained. They were credibility, dependability, confirmability, and 
transferability. 
Trustworthiness oftlte Study 
Credibility 
Credibility measures how vivid and fa ithful the description of the phenomena is 
and provides the standard for judging their truth value (Streubert Speziale & Carpenter, 
2003). Family members at high ri sk for HNPCC and who participated in genetic testing 
are considered to be the experts and therefore are the most credible source of 
information. A qualitative study is considered credible when the participants recognize 
the descriptions and interpretations of the experience as their own ( andelowski, 1986, 
1995). The credibility ofthe study 's findings was enhanced by havi ng two researchers 
independentl y prepare an interpretive summary of each participant's interview and then 
reaching consensus on the content. At the final step interpretive summaries were 
reviewed with participants to seek additional clarification and confirmation. 
Dependability 
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Dependability measures how stable the data are over time or across situational 
contexts (Streubert Speziale & Carpenter, 2003). Dependability of the findings was 
established by validating model constructs and properties with additional members from 
the exon 8 families accessed in the original qualitative study, as well as recruiting 
individuals from new families with the exon 8 deletion. Another way in which 
dependability was enhanced was selecting family members from variant age groups, 
primary cancer sites, and lengths of time since genetic testing. 
Confirmability 
Confirmability refers to the ability of an independent researcher to fo llow the 
decision trail as conveyed by the study findings (Streubert Speziale & Carpenter, 2003). 
That is, the method and findings must provide an audit trail for other researchers to 
follow in an understandable and predictable manner. This was accomplished in two ways: 
(1) the ease experienced by this researcher in using the coding and analysis process 
outlined in the first study to confirm model constructs and properties with the data 
received from other members of families with the exon 8 deletion mutation, and (2) the 
ability of o ther researchers reading the study results to follow the logic of the 
interpretations and conclusions. 
.----------- -----------
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Transferability 
Transferability refers to the applicability of the results to other related groups 
(Streubert Speziale & Carpenter, 2003). This study set out to augment and confirm the 
experiences of those family members who were tested for the intron 5 splice site MSH2 
mutation on exon 5 eight to ten years ago. The results of the exon 8 deletion family 
members, who were tested more recently, are therefore applicable to those tested 
previously. As well , this model is being tested for transferability in those who have been 
tested for another genetic condition, including arrhythmogenic right ventricular 
cardiomyopathy (ARVC), increasing the transferability of this study's findings. Current 
study findings will now be presented in the following chapter. 
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CHAPTER4 
Results 
The findings are presented in four sections. The first section presents a summary 
of participant characteristics. The second section presents an overview of the conceptual 
model, Confronting and Accepting the Challenges of Living in Families with Genetic 
Linked Diseases, derived from the original grounded theory study. The third section 
summaries the findings on each major construct of the model from individuals in families 
with the exon 8 deletion mutation. The final section presents a brief discussion on how 
the study findings confirm the major tenets of the original conceptual model and augment 
its properties and descriptors. 
Descriptive Profile 
Most ofthe 12 study participants were female (75%) and had at least one child 
(91.67%). All had a partner and were part of three distinct fami ly units. The average age 
of participants at the time of the study was 50.17 years (SD = 7.81 ; range 42 to 66). All 
of the participants lived in families with a strong history of colorectal and extracolonic 
cancers and had experienced cancer onset in a parent. This event occurred for most of 
them (58.3%) in childhood(< 13 years) or adolescence (13 to 20 years). 
Study participants took part in genetic counseling and received their test results 
between 2002 and 2004. The sample was equally divided between HNPCC carriers and 
non-carriers. The mean time from receipt of test results to the initial qualitative interview 
was 2.26 years (SD = 1.27), with a range between .08 and 3.75 years. Most of the carriers 
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had reached the affected stage at least once (66.67%) at the time of the study. The cancer 
type varied with three carriers experiencing one primary site (CRC, endometrial or skin) 
and one carrier with two primary sites (endometrial and kidney). 
Conceptual Model 
The conceptual model proposes a broad theoretica l representation of the 
psychosocial and behavioural impacts of genetic testing for HNPCC from the lead-in 
through genetic testing to the post-test periods. This theoretical repre entation illuminates 
significant influences beyond genetic testing by casting light on factors which have been 
given only cursory attention in the literature. 
The first construct, living in families with a strong history of hereditary cancer, 
describes the phase prior to genetic testing for HNPCC. It depicts what it is like to live 
within a fam ily with an ominous cancer presence and to eventually awaken to the idea 
that these cancers could be hereditary. The second construct, becoming aware of genetic 
testing and living the process, outlines how fam ily members decide to become involved 
in genetic testing, react to being informed about their carrier status, perceive the 
supportiveness of genetics personnel, understand their risk, and are willing to 
communicate genetic testing findings wi thin and outside the fami ly network . 
The third construct, struggling to adjust, describes the personal and fam ily 
challenges following genetic testing for HNPCC. Consideration is also given to 
significant personal and fan1ily factors that may faci litate or impede overall adjustment in 
the short- and long-term. Most important among these are the extensiveness of screening 
protocols, cancer occurrences/recurrences in the self and others, the effectiveness of 
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screening and treatment modalities, and the receptivity of children to becoming involved 
in genetic testing and, ultimately, screening. 
The first two constructs, living in families with a strong history of hereditary 
cancer and becoming aware of genetic testing and living the process, are conjectured to 
exert a direct impact on each other and a direct and indirect impact on struggling to adjust 
(see Figure 2). It is also proposed that accepting the challenge is the unifying thread that 
links the constructs, signifying that a change in one area has repercussions for other areas. 
For example, as children awaken to the idea of a cancer genetic link in the family, more 
family members reach the affected stage, or family relations become more disrupted with 
loss, individuals may or may not accept the challenge to seek answers about their own 
HNPCC risk and, even if they do so, may not cope well with either their carrier status or 
disease management. 
Finally, all three constructs are believed to exert a direct impact on quality 
outcome, which is seen as an evolving state. The third construct, struggling to adjust, is 
also conjectured to mediate the effects of living in a family with a strong history of 
cancer and becoming aware of genetic testing and living the process on quality outcome. 
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Figure 2. Confronting and Accepting the Challenges of Living in Families with Genetic 
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HNPCC Families with Exon 8 Deletion Mutation - Model Findings 
The discussion of findings is organized according to each major construct of the 
model. The content of each construct is, in turn, divided in terms of its defining 
properties. 
Living in Families with a Strong History of Cancer 
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Data from the interview transcripts of exon 8 deletion participants confi rmed the 
first construct of the model. The first construct refers to the lead-in period of the genetic 
testing process and consists of two properties: (1) struggling with multiple losses -
conflicting emotions, and (2) searching for meaning/understanding/certainty. 
Struggling with multiple losses - conflicting emotions. This property captures 
how family members deal with increased cancer incidence and prevalence as well as 
early losses of close re latives from the disease. Most participants were fami liar with the 
strong presence of cancer in the family. For some, the awareness of a like ly hereditary 
component to colorectal cancer had been passed down from previous generations: "She 
[mother] would say, ' Live as long as you could just like you are and you ' ll get a longer 
time out of it because it [colon cancer] is in our family' ." 
The stories relayed by several participants highlight what life is like when one is 
forced to endure the prolonged suffering of a close family member who never seems to 
escape the disease. The continuous onslaught of cancers creates a cumulative effect and 
compounds the level of uncertainty. One participant' s recounting of her mother's cancer 
recurrences over a 30 year period captures the sentiments of others: " It r cancerl has 
almost had ten year increments really when you think about it. Every ten years she 
[mother] has been faced with a cancer diagnosis." 
59 
The high cancer presence in the fam ily and early losses from cancer had 
significant emotional effects on participants. For many of them, events with the greatest 
impact were recalled most vividly, recanted in detail and sometimes evoked strong 
emotional reactions. One participant, who was a health care provider, spoke about how 
difficult it was caring for her mother: " I can remember rubbing her back and feeling 
everywhere and thinking how many tim s have I done this to someone else and it was 
[very difficult] ." Another participant, who was very close to her brother, described how 
difficult it was being vigilant and supportive while he endured so much pain and 
suffering before dying at 38 years of age: " [Six years] he [brother] went through hell. 
That's all I can call it." 
As participants encountered more and more cancer in the family, the disease 
increasingly took on a fatalistic meaning. There was a dawning of sorts that this disease, 
although not yet discussed in terms of genetics, was something passed down from one 
generation to another. The following quotes illustrate this: 
And we watched our grandparents or great grandparents go down in the ground. 
That was it because of cancer - this deadly, this monster. There i no controlling 
this monster. That's it. 
----------------------------------
Once you had this colon cancer thing or whatever it was . .. if you were in the 
family and you were the one that had [cancer], we didn't call it a gene or 
anything, you didn ' t stand a chance anyways. This is the way we fe lt. 
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Against this fatalistic background many participants believed that it was just a matter of 
time before cancer would surface. Two siblings tried to prepare themselves and 
significant others for this eventuality: 
It's like whenever something would happen in our family ... with my sisters and 
my mother and father, my cousins or whatever, we would talk on the phone, and 
we would say I guess we' re next. You know you're just like little ducks, and 
you' re the next one; ticked off type thing. 
I've always felt personally that if I got out of this world not having cancer I was a 
very lucky person. So deep down ... s ince I' ve been twenty-ish, I' ve always 
thought well somewhere, some day, some how they ' re going to say, me. 
When cancer surfaced on a personal level, the disease assumed new meaning for 
the self and one ' s offspring. Younger participants seemed to struggle more wi th the 
psychological and physical sequelae of managing the disease. One female spoke about 
the emotional difficulties that she experienced when diagnosed with endometrial cancer 
at 40 years of age. 
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She [gynecologist] did my hysteroscopy and five days later I get a call. I had clear 
cell carcinoma which is very aggressive and it was in one of the polyps that the 
ultrasound was showing as a small fibroid .. .. So anyway that was it. It was a real 
roller coaster after that. 
For individuals, with non-HNPCC cancers on the unaffected s ide of the family, 
the potential for interactive effects played havoc with their ability to grasp their perceived 
personal risk. One participant commented on how her son believed that he could be at 
increased risk for both HNPCC cancers and prostate cancer: "My son at age 40, bless his 
heart, he feels like he got a double whan1my now where his father just had prostate 
cancer at 65." 
The extended period of cancer occurrences and losses within families also had the 
potential to disrupt family relations and decrease the number of members available for 
support. Although most families remain unchanged, some relations are weakened while 
others are strengthened. It seems that younger family members may have to make greater 
adjustments. Participants from two separate families were in their earl y to late teens when 
first exposed to cancer in a parent: " I think our life just kind of revolved around Mom 
was sick and we had to kind of do things, certain things she couldn ' t, and you know I 
think it just became a way of life" ; "She [sister] wasn' t in school [when mother 
diagnosed]. We all had to take our turn automatically you know cleaning the house, doing 
the dishes and chores. We all had to pick up our slack and help out." 
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Searching for meaning/understanding/certainty. The awakening period prior to 
confirmation of a genetic link was shaped by the level of awareness of cancer in the 
family. A lthough most participants had been exposed to a relative with cancer during pre-
adolescence, it was not until their 20s and 30s when cancer recurred in a parent or 
surfaced in other family members that they developed a greater appreciation for its 
hereditary nature. In many cases, family physicians and specialists alerted members to the 
need to be vigilant about the disease: 
A ll this cancer and I mean I am impressionable at 20 [years of age]. The doctors 
were saying, "I think people should be watched here '. This is j ust not om fami ly 
doctors. I guess they [specialists] knew so many of the family . ... You know my 
cousins, my unc les, my aunts. So they could see what was really going on here. 
Due to previous cancer events in close relatives (mother, father, brother or sister), 
screening was sometimes initiated before fo rmal awareness of a genetic link. One male 
partic ipant initiated screening upon learning about his potential high risk for cancer: " Up 
until the time that I found out that I wasn' t the gene carrier, I mean I had the 
colonoscopies done every two years." 
Conversely, participants who were not exposed to cancer illness in a parent or 
c lose family relative until mid-life were not aware of the full extent of its presence. Thi 
meant a shorter awareness period going into genetic testing. One female part icipant noted 
that it was only when her mother was diagnosed with cancer at 67 years of age that she 
started looking fo r answers: " It must be then with Mom [cancer] that we actua lly made 
the connection to think okay there 's something wrong here."; "We started looking for 
information for a family tree. We knew that there were still lots of cancer there but 
actually how much [we didn't know]." 
For participants who suspected a hereditary basis for the familial cancer, the 
availability of genetic testing for HNPCC was a welcome relief for their growing 
concern. One female participant captured the generally high level of acceptance and 
readiness of most family members to become involved in genetic testing: 
Our reaction to that [availability of genetic testing for HNPCC] was again there 
would be no big surprise because of living in my fan1ily with cancer for a long 
time .... There was no di scussion, like, maybe we should, maybe we shouldn 't. 
That didn 't enter into the picture. Yes we will do this. 
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Summary. It was apparent from participants' stories that living in a family with a 
strong history of cancer shaped personal beliefs, vulnerabilities and rudimentary 
hereditary understandings. The impact of familial cancer experiences on personal risk 
perceptions seemed to be even more dramatic for those exposed at younger ages. For the 
most part, these individuals were more accepting of a genetic link and the necessity for 
regular screening prior to genetic testing. Certainly acceptance of one's high-risk status 
was a significant motivator behind an individual's decision to test. 
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Becoming A ware of Genetic Testing and Living the Process 
The data from exon 8 deletion participants also supported the second construct of 
the model. The second construct focuses on the actual genetic testing period and is 
defined by three properties: (1 ) moving closer to puzzle completion, (2) the meaning of 
genetic testing, and (3) communicating with others. 
Moving closer to puzzle completion. The lead-in period is a key component of 
genetic testing. Participants' willingness to become involved in the process was heavily 
influenced by motivational and risk perception factors, fami ly members' acceptance, and 
the perceived availability offormal and informal supports. 
Genetic testing provided participants with an opportunity to bring greater 
certainty to personal risk status and, ultimately, to future generations. For many ofthem, 
it was now possible to find answers to why so many family members were suffering and 
dying from cancer: "To say that we will find out what's going to happen [concerning 
cancer risk], knowing made a big diffe rence. Just the anticipation of knowing, well we 
are finally going to know." For others, genetic testing came as a surprise. Despite only 
becoming aware of the possible hereditary link as relatives reached the affected stage, 
these participants were also able to appreciate the benefits of genetic testing. One man 
described the benefits as such: " I came with the frame of mind that it [genetic testing] 
might not do me any good. But then again I' m still only a young man, 46 years old. It 
may do me good." 
A igni ficant motivational force was the desire to protect ch ildren and 
grandchildren from the disease. One woman' s comments captured the sentiments of 
many others: "My thing was that I have seven children and God knows how many 
grandchildren I' m going to have so this might help my family." Because of the obvious 
implications for future generations, it was difficult for study participants to understand 
why some family members chose not to become involved in genetic testing. Several 
participants were of the opinion that those refusing were not making wise choices. One 
female non-carrier expressed concern that their children could be at risk: " Well I don't 
think [Uncle 1 's daughter's son] did because he got cancer, he just assumes he got the 
gene anyway." 
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Time frames between the offering of genetic testing, blood submission and the 
availability of results varied across families. Some members are informed of the 
possibility of genetic testing early in the identification process, submit blood for testing, 
and then wait for a prolonged period before the family's HNPCC mutation is uncovered 
and individual results become available. Other members are informed of genetic testing 
closer to gene mutation identification and thus receive their results in a more expedient 
fashion. Most participants described the wait-time as an unwanted distraction: "From the 
time that the blood was drawn until 1 actually got the result, 1 shouldn' t say [it] didn't 
make a diffe rence to me whether it was negative or positive, because it certainly does. 
But the waiting was worse." 
Tile meaning of genetic testing. This property captures participants' reactions to 
test results, perceptions of support from genetic personnel, understandings of the 
implications of their HNPCC status, and perceptions of the benefits and liabili ties of 
genetic testing. Processing of information received about one' s carrier status occurs on 
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both cognitive and emotional levels. What surfaced as significant for acceptance of one's 
HNPCC status was existing beliefs about inheritance patterns within families. 
Some participants relied on beliefs about inheritance to speculate about who 
would most likely inherit the gene mutation. Gender, physical characteristics, and 
manneri sms surfaced as important factors. One participant believed the family's cancer 
was much more prevalent among females: "That's the way it presented in my mother's 
family, every single girl had cancer, not one of the boys. Now since then, one [male] has 
but he is in his 70's. You know you do not count that." Another pa1ticipant bel ieved that 
physical likeness to the affected parent was relevant. "Even before I knew my results, you 
base things on well my sister is more like my father than I am. I am more like mom. So 
my sister is more likely to have thi s gene and not me." 
Although lay beliefs about cancer inheritance have very li ttle scientific re levance, 
coincidental mannerisms helped some participants speculate about more susceptible 
family members. One woman commented on what she observed or what was reported to 
her about fam ily members who had colon cancer. 
My mother had to have well water. My brother had to have well water. This is the 
connection to colon cancer. Like they just knew it and they all died in July every 
one of them .. .. That's not medical related, but that's how my fam ily has dealt 
with it. 
Despite feeling well prepared to receive genetic testing results, some carriers, and 
to a lesser extent non-carriers, experienced unexpected emotional reactions. A disconnect 
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seemed to exist between understanding what their HNPCC results meant on a cognitive 
level and accepting them on an emotional level. The emotional fallout is most likely due 
to the lengthy period of being exposed to cancer in the family prior to genetic testing. 
One carrier commented that genetic testing had somehow given her an additional 
burden because of so much uncertainty about the future: " It [HNPCC carrier] left me with 
this really eerie sense that there is always something just over that little left shoulder of 
yours. It is just that one little thing that you had to can·y around somewhere." Another 
female carrier commented on the anger she experienced and how surprised she was to be 
having such a negative reaction: 
I went in there totally prepared for a positive result. I knew what was in front of 
me. I knew what it meant. I never second guessed myself once .... I was adamant 
I wanted to know but the instant that I knew I wished I didn't. ... I remember 
driving out from [main city] like totally angry thinking oh for the love of God is 
there a real need for this. I was really surprised at myself for having that reaction. 
This same person continued to have periods of doubt concerning the utility of genetic 
testing and oscillating feeling states for a protracted period of time post-testing: " I would 
say, 'what did l get this [genetic testing] done for. ' I wish 1 never knew I really did. There 
are sti II times that I feel that way ... I guess I'll be going through cycles." 
For the most part, non-carriers of HNPCC experienced a sense of closure to the 
life-long uncertainty of developing cancer. As well , they benefitted from not having to 
endure frequent colonoscopies and other recommended screen ing protocols. Their 
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comments conveyed an uplifting experience - a sense of relief, lifting of a burden, and to 
a degree a new lease on life. One non-carrier commented: " It made me feel better too, 
right .. . when I found out I didn't have it because it was going to make them [my children] 
feel better." 
There was also a downside to being a non-carrier in a family with a high 
incidence of cancer and losses from this disease. As certain participants noted, although 
they were spared having to contend with the disease personally and/or passing it on to 
their offspring, they still carried the emotional burden of knowing about other close 
members ' status and: "You' re negati ve but then you feel bad for the rest of the family . 
. . .I have to be honest I cried for [Brother 1 ].";"I worry a lot about my sisters . . .. And 
every time she [younger sister] gets something wrong, I' m wondering, you know." 
Most participants were generally sati sfied with the support received from genetic 
counselors immediately following receipt of test results. One participant commented: 
"They [genetics personne l] were excellent, I must say. It was really good, really 
understandable." With privacy issues an important consideration for some, a couple of 
participants noted that the genetic counselor was able to be supportive while maintaining 
confidentiality concerning the status of other family members. 
She [genetic counselor] wouldn ' t disclose anything about my sister and I can 
understand that. She is such a sweet lady you know - very mild and leads up to 
the situation. I mean there is nothing that she springs on you. 
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I sat there and she [genetic counselor] come out and sat down and sta1ied 
explaining everything to me. [I thought], "I guess there's something here 
somewhere in a minute she' ll tell me [my result]." That' s all; I didn't get upset or 
anything. She said, "[Name] your test is good, right." I said, "That's great." She 
gave me a hug. 
In order to fac ilitate greater understanding and acceptance of the information 
conveyed during receipt of results, genetic counselors asked participants to bring support 
persons with them. Nevertheless, two sisters had to convince the counselor of the merits 
of receiving their results at the same time. 
She [the genetic counselor] was really kind of saying to me, "Well may be it 
shouldn't be your sister. ... [I said], " Well if she doesn't come with me, I am not 
going. [Ha, Ha] ... my sisters were the only ones that I really felt confident enough 
that no matter what it [result] was, well we were going to have to deal with it for 
the years to come too. 
On another level this participant understood the ramifications of being in a situation 
where one was positive and the other negative. She commented thus: "I think it would 
have been guilt at that point [if one were positive and the other negative]. I am happy for 
me but I am sad for you, so what do I do?" 
An important outcome of the genetic testing process is the decision-making that 
occurs subsequent to the receipt of results. Arguably individuals who test positive are 
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under considerable strain at this point, especially in the absence of personal signs and 
symptoms of cancer. Nevertheless, optimal well-being in the short- and long-term is 
contingent upon balancing the plusses and minuses of preventive actions to delay cancer 
onset and progression. 
Adequate understanding of one's risk for developing colorectal and other cancers 
following genetic testing is important for both carriers and non-carriers of the HNPCC 
gene mutation. For the most part, non-carriers understood that their cancer risk was the 
same as the general population. Nevertheless, some of them continued to feel vulnerable, 
which seemed to be a function of general cancer worry: "We still got the chance of the 
general population. With genetic testing well , it will just tell you if your odds are any 
higher to get this certain type. But to me I'm in a risk [category] anyway." Another part of 
non-carriers continued vulnerability stemmed from worry over children. One non-canier 
indicated that it was still a good idea to have the children tested or at least screened on a 
regular basis: "I have my children who are not positive getting tested [screened]. They 
don't care." 
All of the carriers generally had a very good understanding of their increased risk 
for colorectal and related cancers, as well as the importance of following recommended 
screening. A couple of siblings admitted that they could not remember all of the specifics 
relayed to them by the geneticist/genetic counselor, but did note that the written 
documentation received helped clarify things: "She [geneticist] did go over that [risk 
percentage for different HNPCC cancers]." ; " I don ' t think we actually retained a lot of it. 
. .. We have letters with that." In order to promote better understanding of her I-INPCC 
risk, o ne participant sourced a website for further information: " I remember the first time 
when I looked at the website and saw the stats. You have an 80% chance - geeze that's 
not real good odds." 
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Due to the variable expressivity of the disease across families, some participants 
had a more comprehensive understanding of their cancer risk than others. In families 
where colorectal cancer dominated, some female carriers underestimated their risk for 
other cancers. One participant discounted the merit of annual endometrial screening. 
They had given me a list of screening. I have been doing it. Of course not as they 
would say .... This transvaginal ultrasound, 1 never had that done. Who does go 
off and get that done every once a year or so? And this CA 125, well who goes and 
gets that done? The colonoscopy, yes, because I don't forget. From the time I was 
born we talked about [it], we had colon cancer. ... It wasn ' t the ovarian, it wasn ' t 
the skin; it was colon cancer. 
Final ly, there is a well defined cognitive and emotional processing that occurs 
among family members that helps them sort out the positive and negative aspects of 
receiving genetic testing results for HNPCC. Knowing that you are an I-fNPCC carrier 
provides a reality check for all carriers with some becoming more motivated to adopt 
healthy lifestyle habits than others. One person had this to say: "The writing is on the 
wall , you wake up, and you say to yourself don't be drinking too much . ... start living a 
healthy life." Another carrier who was motivated to screen regularly benefited from the 
early detection of cancer: "I'm glad it is being done .... I would not be here if it wasn't for 
the screening process." 
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One of main plusses of knowing one's HNPCC risk status is forewarning. 
Carriers are alerted to the importance of maintaining screening to promote early detection 
of the disease. One carrier saw the benefit of seeking medical attention for early warning 
signs that may have been ignored in the past: 
I think that once you know that you have the gene, it will affect you to the point 
that if you get an ache or pain that is probably the first thing that is going to come 
to your mind which will probably send you to a doctor quicker than if you were 
not. 
Other carriers recognized that knowledge of their risk status would benefit current and 
future generations and they hoped their involvement in predictive testing would one day 
lead to the HNPCC gene mutation being repaired . 
It would be wonderful to know that somewhere down the road, that little drop of 
blood that we gave played a key role in figuring out what in the name of God 
went terribly wrong. If we can get that mutation fixed, vaccine, anything, I'm all 
for that. 
A downside to being aware of one 's carrier status is not knowing when cancer 
will occur, what organ it will attack, how severe it will be, or how responsive it will be to 
treatment. One female carrier had this to say: 
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It [confirmed carrier for HNPCC] doesn' t necessarily mean that I'm going to pop 
off anytime soon but chances are I don ' t think I'll live a real long life, I don ' t. I 
guess that 's why it' s so important to me not to be spending my time running 
around the health care [system] and that now. 
Another carrier questioned the true benefits of genetic testing for HNPCC and regular 
screening when both fail to alter the outcome. 
My cousin that passed away ... her son ... knew of every test that was available that 
she should have done. She strut ed with ovari an and then it was all through her 
body. But she lived several years and it still ended up to be the same thing - died 
from colon cancer. So you really wonder if the results [death] ru·e the same what's 
the good of genetic testing. 
Non-carriers a lso had a mi xture of positive and negative feelings about knowing 
their HNPCC status. One female participant summed up her fee lings: 
I thought it was great first. Trying to keep that oral fleet down was terrible. I was 
thinking, " Wow I don' t have to do that now fo r another few years and I' m reall y 
feeling good." Then I got home and I thought about it ... " Is this a good thing or 
is it not a good thing?" Before I was getting it [colonoscopy] every year .. .. Now 
I' m think ing, "Hum, it ' s like it was a crutch, and now that crutch is gone." So I 
just watch myself a little bit more carefully. 
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Communicating with others. Family dynamics play a very important role in 
deciding who becomes privy to information about HNPCC risk and genetic testing. 
Within exon 8 deletion mutation fan1ilies, differences exist in how willing individua ls are 
to be open about their HNPCC status to close and distant family members. The level of 
disclosure to the children was often guarded, with participants remaining highly sensitive 
to the potential for negative reactions. 
Obvious differences ex isted in how carriers and non-carriers communicated wi th 
their children and other members of their social networks. For non-carriers, the results 
were favourable and the news about their status was communicated in a swift and 
uplifting fashion. One female participant felt a great sense of relief and excitement and 
openly shared the good news with others: "Our daughter came home that afternoon 
because she had been at university [and I told her I was negative]. My best friend, I called 
her because she was waiting as well. We were a ll really happy about it." 
For carriers, there was a general tendency to engage in greater de li beration and 
discussion about when and how to inform their children. Many of them struggled with 
how much information to convey to their children and at what age. One carrier felt that 
her children were too young to be to ld and chose a more reactive approach to gauge their 
level of readiness. She be lieved that thei r exposure to cancer illness in family members 
would naturally stimulate inquiries about HNPCC and genetic testi ng. 
Well it was a year or so after I knew my results that it came up in conversation 
w ith mom where my children [were present] about having this genetic testing 
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done. When I went home my daughter asked me, "Did you have that done?" I felt 
she was 11 or 12 years old and my son is three years older and they were both 
si tting there and I didn' t feel the need to lie and I said, "Yes I did." So it was just 
kind of quiet and I said, "I did have it done and mom is positive." 
An important emotional barrier was perceived reactions of the children to 
knowledge of their parent's carrier status. One female participant used an individualized 
approach to communicate with her two children. The child who was receptive was 
informed of her carrier status right away: " I gave it [information sheet from genetic 
counselor] to my son. He called her [genetic counselor] and of course hence he went out 
and had his testing done." Knowing that the other child would be le s receptive, she 
chose a more guarded approach. As expected, the daughter was opposed to genetic 
testing and decided not to share this information with her two adult children: "But with 
my daughter l couldn't give it [information sheet] to her because she wanted no part of it 
[genetic testing]." 
The responsibility of communicating to children may create add itional 
psychological burdens for carriers. Many carriers are unsure of any formal mechanisms 
available to help them with this task. One male participant expressed concern over his 
inability to convi nce his children about the seriousness of the HNPCC risk. 
My 22 year old daughter [i s able to see the benefits]. My son is not [going for 
genetic testing] . . . . Because he' s not going to be able to do this, do that. I keep 
telling him no, that' s not true. He's 2 1 .. .. How do l educate them [children]? l can 
only talk to them, I mean I can' t force or drag them in here. 
Another female carrier expressed a need for assistance in order to effectively 
communicate information about the HNPCC risk in the family to her children. 
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They [daughter and son-in-law] had a lot of questions for me that I couldn't 
answer. 1 need someone now to tell me the answers to the questions so that I can 
tell them ... .It is a big problem for me. 
Close family ties and open communication patterns helped facilitate disclosure 
about the HNPCC risk in the family. Overall, it appeared that information sharing about 
HNPCC was greater among immediate than extended family members. One participant 
who had an affected sister was aware of her battles with cancer, but less certain about the 
details of his uncle ' s family: " I don ' t know if my [paternal] Uncle 3 had cancer when he 
died I can't remember what he had. Some of his children died with cancer [first cousins 
on paternal side]." A non-carrier from a close-knit family noted that physical distance did 
not hamper their discussions. 
I have cousins who are still being tested because there were so many of us .... 
Even though they are on the mainland, we still see each other. ... we still have 
contact through their parents .... We still know what's going on in their lives. 
What is troubling here is that the policy of re liance on family members to communicate 
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with one another about the risk of HNPCC and the importance of genetic testing may not 
be prudent if they are not provided with access to formal psychological supports: "We do 
talk about it [HNPCC testing] but it's hard for us to sit around and talk about it because 
my brother just lost his daughter 17 years old. So it 's hard to even bring up that topic 
now." 
Even in the presence of strong family supports, caniers and non-caiTiers 
sometimes concealed information about genetic testing from others. All of the s iblings in 
one family tried to protect their mother from additional burden: "At that point mom knew 
that I tested positive but I had not had the conversation with her. Had she asked me I 
would not have lied. I just fe lt that she had tackled enough in her lifetime." 
Summary. Exon 8 deletion participants viewed genetic testing as an opportuni ty 
to bring greater certainty into their li ves. Importantly, the amount, intensity and level of 
awareness about fam ilial cancer influenced how individuals made decisions around 
genetic testing. Support from geneticists and genetic counselors prior to and during the 
process were deemed valuable. Nevertheless, the real work of emotionally adjusting to 
one' s results occurs at the individual and family levels. /\midst the positive and negative 
aspects of knowing one' s personal risk status is communicating this informat ion to other 
family members. It is through such communications that a full understanding of the 
causal factors for the cancer and what can be done to modify one' s risk becomes known. 
Struggling to Adjust 
T he third construct, struggling to adj ust, focuses on the period after genetic 
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testing. It is defined by two major properties: (I) coping with HNPCC risk - personal and 
family challenges, and (2) identifying and addressing barriers to successful coping -
engaging in recommended screening protocols, dealing with cancer onset, and accessing 
cancer care in a timely fashion. 
Coping with HNPCC risk. This prope11y captures two key aspects of coping -
personal acceptance and family burden. The presence of the HNPCC gene mutation in 
fan1ilies has s ignificant implications for, not only confirmed carriers, but also non-
carriers. Overwhelming demands on individual family members can threaten the entire 
system 's ability to cope and adapt in an effective manner. The family's ability to adjust is 
influenced by the cohesiveness of its structure and communication patterns within and 
between units. Carriers ' acceptance of their status, willingness to be proactive in disease 
management, and receptivity to the giving and receiving of support are a lso impo11ant to 
successful adjustment in the short- and long-term. 
All of the study participants reiterated the importance of maintaining a positive 
attitude toward one's carrier status, cancer onset and the usefulness of treatment. For the 
carrie rs, the emotiona l toll of waiting for the disease to recur or manifest itself for the 
first time ebbed and flowed in response to one ' s inner strength and the perceived 
supporti veness of family and friends. A couple of individuals, who had not reached the 
affected stage, spoke about how difficult it was to remain positive wi th so much cancer 
all around them: 
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Yes many are touched by it [cancer]. And some are way younger than her 
[mother] and some are like a shock - ' Wow, how could this person be so healthy 
and how did this happen?' I think that has to play on your mind. 
They [children] just lost their cousin, 17 years old. How do they deal with that? 
We' re finding it difficult to deal with and not only that we watched her die. She 
just didn ' t die we watched her melt away. 
The carriers who had reached the affected stage articulated how they attempted to 
stay positive and rise above the conflicting emotions posed by the illne s. One carrier 
commented on how a second bout of cancer weakened her outlook and caused her to 
reflect on the uncertainty of her future. 
I don ' t sit and dwell. Yes we all do; especially last year when 1 got sort of down 
and I got cancer again ... . What else is going to happen to me now? Oh God, when 
is it going to break out next." 
Nevertheless, she was cognizant of the importance of staying positive and re i ied on self 
talk to build up her inner strength: " 1 have to survive. I have to carry on and you can' t 
dwell. I kind of have to give myself a little smack now and then and say smarten up, you 
know get on with it, it' s life." 
Another affected female carrier spoke about how she struggled to remain positive 
when cancer was literall y all around her at home and at work. 
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I think because of my diagnosis and because of mom's situation [terminal cancer], 
and probably because I ' m in a health care setting, it seems like not a day goes by 
that I'm not dealing with cancer and counseling people and arranging tests. I think 
sometimes you run out of steam because you are always keeping up the positive 
attitude. 
This person stressed the importance of being mindful of one's high-ri sk status, but not 
allowing it to control you: " I try my best to live by it [positive attitude]. Cancer has such 
a weight associated with it. We all need to dwell at a certain point, and it's important to 
do that but we can' t facilitate it." 
Still another affected canier coped most effectively by avoiding any thoughts of 
cancer for most of the year. Her comments suggest that because she was having great 
difficulty adjusting, she prefened to only acknowledge things during annual screening: "I 
need to compa11mentalize it. ... Like l said about the one stop shopping, once a year I'll 
admit it, kind of thing. The rest of the year denial is a love ly thing, I can just forget about 
it." 
Although non-carriers experienced tremendous personal relief from not being at-
risk, they still reta in the burden of having to interact with and, in some instances, provide 
care to carriers. Their level of burden is a function of the strength of establi shed 
relationships and being willing to sustain clo e ties with carriers. One non-carrier 
provided insight into why she continued to struggle to maintain a positive attitude as 
other family members received confirmation of their catTier status and/or reached the 
affected stage: 
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Since I've had this wonderful news that I don ' t have the mutation, two of my 
younger cousins are now having problems. One had his colon removed not for 
cancer but because he had so many polyps ... . His sister a few months later 
has bilateral lung cancer - she' s 36 years old .... So like you go along in this 
family and you're thinking .. .. It's not just off there in the distance; it's right 
up there in your face all the time. 
The impact of testing positive for the HNPCC gene mutation is not restricted to 
the individual receiving the news, but also influences spouses, children at1d other fmnily 
members. In some families, the presence of a cohesive structure enabled members to rally 
around the latest person to become a confirmed carrier or to develop cancer. When a 
person is the first one in his/her generation to be diagnosed with cancer, it is sometimes 
difficult to share the news with other members so as not to negatively impact them. This 
seems to be especially difficult when the contributing parent is still alive and the affected 
person has young children who could be also at risk. 
When I think of all the people I had to tell [about my cancer] . No offence to my 
mom, you know my son was the hardest. That was the toughest for me. But the 
second person, even more than my husband, was my mom only because 1 knew 
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what she was going to feel like. I knew what that experience was going to be for 
her. But I handled it well I think. 
This participant also discussed how, over the years, family members became more 
familiar with individual strengths and weaknesses and who could or could not be called 
upon in different situations: " We all have different roles that we do very well. We've 
kind of learned through the years where we excel. We are all not good at everything." 
All of the carriers spoke about the comfort of knowing that there is at least one 
person in their social or family network available to them to discuss their fears and 
concerns. Two female carriers highlighted the importance of having someone there as 
needed. 
She [female cousin] has been a great source of strength for all of our fam ily - fo r 
myself and my sister because we're you know close to [Cousin 1]. She called me 
this morning to see how I am .... See she' s really supportive. 
The one cousin who I know has also tested positive, he ' s gone through a lot ... 
had his colon removed. We were never very close but like now we call each other. 
I guess it ' s kind of that . .. even though I haven' t gone through what he 's gone 
through we' ve become closer. 
ln contrast, other families were more conscious of an individual 's need for 
privacy and time to ass imilate the info rmation about his/her carrier status or recent health 
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threat. Participants from these families tried to maintain a healthy distance while leaving 
the door open to provide support. 
We do talk about it but it's hard for us to sit around and talk about it. Because 
okay let's give you an example, my brother j ust lost his daughter 17 years old. So 
it's hard to even bring up that topic now. If we can get a year or so off without 
tragedy, we probably will sit down. 
Although some non-carriers felt that it was a challenging experience dealing wi th 
hereditary cancer in the family, they did acknowledge that it helped forge closer 
relationships in some instances. The following quote illustrates this: " I think actua ll y it 
has made our fan1ily a lot closer. Well, we are very close with my mother's siblings, and I 
think it is because everyday well it could be anybody. And you just need to be there for 
them." 
A final aspect of coping focuses on having to confront new issues for the self and 
for one's offspring. A great source of worry and concern for carriers was the possibility 
of or actually having passed on the 1-lNPCC gene mutation onto their children. One 
affected carrier with several children prayed that none of them would carry the gene 
mutation. "1 was praying that they all would be negati ve . .. . But I said, what are the 
chances of that? ... Usually its split down the middle, isn't it?" Carriers also worry about 
their children's ability to accept their potential risk and, if necessary, adj ust to screeni ng 
requirements. One carrier commented thus: " 1 can say this, that when my children are 
tested and one of them is positive, I think that it will affect me way more than my being a 
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carrier." 
The guilt of knowing that one may have passed the germ-line mutation for 
HNPCC onto one's children and grandchildren is a source of constant worry and concern. 
One affected carrier, who endured a lifetime of watching close relatives suffering from 
cancer and eventually succumbing to the illness, struggled to overcome the sense of 
responsibility toward her children, grandchildren and nieces/nephews. 
Now I look at my grandchildren. It never leaves me, yeah it never leaves me. The 
guilt never leaves me. 
And the guilt stays each time I see my niece, each time 1 see her little girl. . . . 
Each time I see my sister-in-law, you know I mean I'm not a morbid person .. . . It 
hits and I think of it and then it 's gone again. We do have our good times, I don't 
mean I' m going around crying all the time, I' m not. 
Identifying and addressing barriers to successful coping. major part of 
adjusting to li fe a an HNPCC carrier i fo llowing recommended screen ing protocols. 
While many family members adapt well to the negative aspects of lh preparations and 
procedures, others encounter diffi culties that threaten continued participation. This 
property focuses on the barriers and fac ilitators to actively engaging in recommended 
screening pro tocols and accessing upporti ve health care provider and services. 
Many of the carriers had endured a long period of screening prior to identification 
of the gene mutation in their families. For some, it was more of the same, but fo r others it 
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became more of a challenge. While discussing the pros and cons of screening, some of 
the carriers highlighted the physical and emotional challenges of disease management. 
One woman spoke about the emotional trepidation experienced during the lead-in time to 
a colonoscopy: " I cry. It's just as well to tell the truth, I cry. I' m weeks before thinking 
about it and I'm dreading it. I'm dreading the day that the test [will come]." A second 
carrier discussed some of the physical barriers to adherence: 
I had had a horrendous experience with my last colonoscopy which was the first 
one done by a new person to me. [Specialist I] had always done it before and I 
hadn ' t had a problem. This other one was absolutely horrendous. I would never, 
ever go through that again. 
The increased scope of required procedures following confirmation of one' s 
HNPCC status was also viewed as a major deterrent to full screening. One carrier 
described in detail how her life was significantly altered by the acceptance of the true 
requirements of 1-INPCC screening: 
I was thinking what has changed, because I was getting screened before. Then I 
thought well I was kind of getting half screened before. 1 was doing the scope 
thing. [was having my transvaginalultrasounds done, and since that I' ve had a 
total abdominal hysterectomy so all that ' s gone . . .. The things that I had decided 
not to do before because I considered they would be really uncomfortable and not 
high enough on the priority list, I have now had those done as well. o I have 
changed. 
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This participant expressed a strong desire for a more normal life: "So a part of me is 
thinking, okay I know why it' s being done, the other part is thinking, I don' t want to be at 
this. l just want to be a normal person." 
As more cancers surface in HNPCC families which are conjectured to be 
associated with the syndrome, there is heightened concern over the ext nsiveness of 
monitoring. Participants were asked to think about possible ways to help make screening 
practices more user-fri endly and potentially increase screening. One carrier highlighted 
the importance of knowing that someone is close-by to help buffer some of the logistic 
barriers to screening: "We' re lucky that I do have my sister and my brother and [femal 
cousin] . . . . o if I have major test or something I would probably go to [her house] and 
stay the night." Another carrier noted the importance of having a personal system in place 
to keep track of appointments and scheduling needs: 
I know that if I don' t keep track [screening appointment may be missed]. . . . I got 
my sheet at home and its all d ifferent colours. Because every year I have it 
[colonoscopy] done, I check it all o ff. The next year, I use a di ffe rent colour. 
One carrier recognized the element of self- responsibility in all this, even in the presence 
of fo rmal supports. 
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Well it's called survival too, you know because if you don' t look after your 
health, no one e lse will. No matter how many friends or family or doctors you 
have in your life, they are so busy doing all their aspects of their lives that if you 
don' t look after [it], and wait for them to call you, forget it. 
Besides needing a personal system of reminders, there is an even greater need to 
have access to health care providers to help fac ilitate understanding of the various 
screening procedures and test results. One female participant commented: "I don' t know 
this terminology. I say to [younger sister] , "What's this that I had done with [urologist]?" 
I know what I need done but I [need to understand the results]." 
Carriers stressed the importance of having access to formal supports to facilitate 
understanding of what is needed to manage their condition, greater continuity among all 
health care providers, and timely access to care. One key aspect of this was interacting 
with supportive caregivers, most especially knowledgeable physicians with good 
interpersona l skill s. What carriers desired more than anything else was receiving 
consistent, accurate and up-to-date information about screening protocols for colorectal 
and associated cancers. One cmTier com mented thus: "You want to be informed [about 
the implications of new information] because you want to protect yourself and you want 
to protect your fa mil y." Many carriers and the ir families express a lack of familiarity with 
the health care supports that they should seek for help as they continue to manage the 
disease. 
Some participants encountered family physicians unfamiliar with the specifics of 
HNPCC. This can be qui te unsettling fo r individuals who rely on physicians to help them 
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with disease management: "The other guy [family physician] she [mother] asked him if it 
[kidney and lung cancer] could be related [to HNPCC] and he didn' t even know anything 
about it." In contrast, encounters with specialists were generally positive because they 
seemed to be more informed about HNPCC. One carrier recalled that her urologist made 
a tentative plan to add more screening pending confirmation of her carrier status: 
Where I've been having those problems the past couple of years with my bladder, 
[urologist] said, 'Now if you tum out to be positive, with what you have done 
[genetic testing for HNPCC] Jet me know because there is another test I need to 
do for you. ' So he was interested. I guess its life, you know, orne people 
[physicians] know a little more. 
Gaps were also identified in continuity of health care and informational 
inconsistencies across specialty areas. One carrier noted that when colonoscopies fai l to 
detect signs of cancer future testing may be extended beyond one year. The variable 
screening protocols recommended by phy icians may potentiate or Jessen the challenges 
confronted by carriers and thus fac ilitate or impede adjustment. 
Not only the surgeon that ' s doing the screening, but I' m seeing this a little more 
often from a c linical standpoint, I' m getting one doctor, even if the scope is 
negative saying okay we will do her in a year. And the next one done by another 
guy wi ll come and say even though she's positive, they are clear and we' ll do 
them in two to three years. 
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In collaboration with specialists, a few participants found ways to streamline the 
screening process and decrease the number of appointment days. One participant 
commented on how working with prov iders to coordinate scheduling and receipt of 
results ensures greater continuity of care, while decreasing the number of visits with 
different providers: "Actually it [breast screening] had been done with another physician. 
So I fi gured leave it with her [Specialist 2] as opposed to going back to my family 
physician. I' m no worse off; I' m still making another trip." 
Study participants also made suggestions about system changes that could help 
them better manage HNPCC in the family. Particular emphasis was placed on the 
importance of resolving identified gaps with genetic testing services and what heal th care 
services are necessary to suppor1 the management of this condition. Many have 
successfully forged their own linkages in the health care system and commented upon 
ways to improve the efficiency of individual and family HNPCC management. 
There should be like a little package. This is what 1 can give to my family doctor 
so that he is aware and here is a I ist of doctors that we have and once you p icked 
these [specialists] notify [genetics] and we can refer the rest of your family there. 
I would like to have one stop shopping, [Ha, ha, ha] I would. Because it seems 
like I' m running around doing this a ll , and 1 don' t want thi s, I don' t need this. I 
know why it ' s necessary to a point. .. . If I could just once a year grease and oil get 
everything done now. Go away, I' ll let you know when I have a problem or 1' 11 
come back in a year. 
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Summary. Personal and family challenges in the short- and long-term period 
following genetic testing interfered with the coping abilities of both carriers and non-
carriers. The ability to maintain inner strength and a positive mindset against the cancer 
threat ofHNPCC became an important coping strategy for carriers. Effective coping was 
measured in terms of one's acceptance of HNPCC status and willingness to adjust 
screening regimes according to cancer risk. Besides the self, carriers experienced ongoing 
guilt, wony and concern associated with potentially/actually passing on the gene 
mutation to children and grandchildren. 
For non-carriers, the burden of care assumed for family members ,who had the 
gene mutation and had or not reached the affected stage, was contingent upon the 
cohesiveness of the fam ily unit, the openness of communication patterns and the 
individual's willingness " to be there" as needed. Finally, most carriers fe lt that 
meaningful contact with formal supports was needed to help coordinate, create 
consistency and faci litate timely access to health system services. Carriers a lso val ued 
up-to-date and consistent information from all hea lth care providers. 
Discussion 
The conceptual model, Confronting and Accepting the Challenges of Living in 
Families with Genetic Linked Diseases, presents a broad framework for the genetic 
testing experience and e lucidates the importance and complexity of the lead-in period, 
while revealing the importance of the presence of comprehensive upports during the 
short- and long-term adjustment period fol lowing testing. Data from the interview 
transcripts of the exon 8 deletion participants confirmed many aspects of the original 
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conceptual model and, in addition, helped clarify and reduce overlap among certain key 
properties defining the major constructs. 
The first construct, living in families with a strong history of hereditary cancer, 
was confirmed by the exon 8 deletion mutation participants. Despite the commonalities 
observed in the stories of participants from HNPCC families, not everyone was equally 
aware of or influenced to the same degree by cancer in the immediate family. For those 
most aware, there was a strong sense of fatali sm toward the disease, limited surprise by 
the suggestion of a hereditary basis, and greater willingness to become involved in 
screening prior to genetic testing. 
The second construct, becoming aware of genetic testing and living the process, 
was also confirmed by participants in the current study. This construct is comprised of 
three defining properties - moving closer to puzzle completion, meaning of genetic 
testing, and communicating with others. Accepting the need for genetic testing for 
HNPCC was heavily influenced by prior lived experiences and perceived high risk for the 
self and one' s offspring. Participants' descriptions conveyed variable levels of awareness 
about the extensiveness of familial cancer and personal experiences with a c lose family 
member who developed cancer and survived it or succumbed to it. 
The meaning of genetic testing seemed to be a function of the adequacy of 
cognitive and emotional processing of information conveyed about one' s test results. The 
degree of concurrence between ex isting beliefs about inheritance patterns and genetic 
testing results emerged as a significant fac tor in promoting acceptance and understanding 
of one' s risk, and greater willingness to adjust one ' s health behaviors accord ingly. Prior 
to the current study, ex isting beliefs about inheritance and developing greater awareness 
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of genetic linkages to disease was categorized as a separate property. However, based on 
the findings from exon 8 deletion participants, it was possible to develop a greater 
appreciation of how lay beliefs about inheritan ce were integral in shaping the meaning of 
genetic testing results. 
The third property of the second construct, communicating with others, captures 
the level of difficulty in disclosing personal risk status to other family members. 
Disclosw-e seemed to vary depending upon closeness offamily re latives, prior levels of 
awareness about the potential genetic link and normal styles of communication in the 
family. This property was a lso reaffirmed by the exon 8 deletion participants. 
The third and final construct of the model, struggling to adjust, captures the 
oscill ating fee ling states of carriers and non-carriers in response to what was happening 
around them, as well as the barri ers/facilitators of successful coping w ith HN PCC. Each 
time participants achieved a sense of stability something seemed to surface to potenti ally 
undermine their well-being and threaten their ability to cope. A second property of this 
construct is the importance that individuals attach to recognizing the barriers and 
facilitators of adequate disease management. An important barrier/facilitator is the 
perceived responsiveness ofthe health care system to families with a confi rmed HNPCC 
presence. A key player in this system is family physicians. Physicians must have up-to-
date info rmation on this condition as well as preventive and treatment modalities in order 
to provide effective and timely care. This construct was further confirmed by the exon 8 
deletion participants. 
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CHAPTERS 
Discussion 
This chapter discusses the experiences of participants from exon 8 deletion 
mutation families according to the three constructs from the model - Confronting and 
Accepting the Challenges of Living in Families with Genetic Linked Diseases. As noted 
in the previous chapter, study findings confirm and augment the model, its constructs and 
properties. The current study's findings also contribute to existing research and clinical 
findings presented in the literature. A summary will be presented at the end highlighting 
the separate and interactive effects of the model constructs on quality outcomes. 
Living in Families witlz a Strong History of Cancer 
The first construct captures the experiential context of cancer fo r individuals who 
belong to HNPCC families. Within this context, risk perceptions for the self and others 
are form ed and rudimentary ideas about a possible hereditary cancer link take shape and 
develop. At some point in time, steps are taken by immediate or extended family 
members, the self or a family physician/specialist to initiate contact with genetics 
personnel to explore the idea that the cancer patterns observed within and across 
generations is be ing passed down. Subsequently, contact is made with someone in the 
family by a geneticist/genetic counselor to initiate the process of profil ing the family 
cancers. Based on these initial findings, individuals who have or have had cancer are 
notified and requested to become involved in geneti c testing for HNPCC. 
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Individuals who are exposed to cancer in a parent or close rela tive at a young age 
often struggle with ideas of becoming affected with cancer themselves. The fatalistic 
meaning of cancer for the self is contingent upon how much suffering the affected person 
endured or whether or not s (he) succumbed to the illness. Many stori es were told about 
how unsettling these experiences were for children, siblings and other family members. 
Comparable findings about the relevancy of the family context for shaping personal risk 
perceptions about cancer and its potential genetic transmission have been reported in the 
literature (d' Agincourt-Canning, 2005; Kenen et a l. , 2003; McAllister, 2001 , 2002; 
Shiloh, 2006). 
What is somewhat unique about the current study's findings is the importance of 
the quality of family relations in helping shape personal risk perceptions. Although 
McAllister (2002, 2003) highlights the importance of open family communications about 
cancer in influencing a person's degree of engagement with HNPCC risk, there is no 
specific reference to how the pervasive incidence of cancer and subsequent losses may 
strengthen or weaken family relations. In instances where famil y relations were 
strengthened (being there and providing support where possible), there seemed to be a 
greater awareness of the need to be more attentive to what was happening to the self and, 
eventually, greater acceptance of one' s personal risk. Conversely, when fami ly relations 
were weakened (continuous avalanche of cancer onset and death diminished the capacity 
of the family support network), there was more of a fatalistic ri sk perception that took 
shape (i.e., powerless to change or alter what is in store for the self health wise). 
Individuals moved to a hi gher level of awareness concerning their personal risk 
for cancer when informed by a family member and/or family physician or were contacted 
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by a geneticist/genetic counselor. At this time, they were alerted to the potential 
hereditary nature of the disease and the implications of this on a personal level. 
Participants reacted differently to being infonned about their potential risk with some 
experiencing surprise and others receiving confirmation of their worst fears . Several 
researchers have found evidence to support the cognitive and emotional movements that 
occur at the individual and family levels when there is a formal acknowledgement of the 
fact that the cancer in the family could be due to hereditary factors (Kenen et al. , 2003; 
McAllister, 2002, 2003; Reeve et a!., 2000; Targum, 2000). 
The decision to become involved in genetic testing for HNPCC is different for 
everyone as it is heavily influenced by the familia l context and individual risk 
perceptions. Personal willingness to accept the possibility of being at high risk for cancer 
is exemplified by actions taken to learn more about the hereditary nature of the disease 
and to engage in preventative screening. Another imp01iant influencing factor 
surrounding an individual's willingness to engage in preventative screening and the 
genetic testing process is the openness of communication within the family and the 
general acceptance of the importance of knowing one's actual risk fo r the disease. 
The findings from relevant research studies concur that many fami lies at risk for 
HNPCC tend to use rudimentary inheritance patterns to seek answers to and to cope with 
their own potential risk status (Kenen et al. , 2003; McAllister, 2002, 2003 ; Targum, 
2000). In many instances, individuals tend to overestimate their risk, wh ich may in pari 
be attributed to the closeness and severity of cancer episodes experienced in the family. 
In contrast, individuals tend to underestimate risk if they perceive the fam ily cancer as 
not severe or they are unaware of its presence. 
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The literature suggests that cancer risk perception takes on new meaning when an 
individual is first introduced to the idea of a fan1ily genetic link. The family experiential 
knowledge base is an important factor influencing the emotional read in ss of individuals 
presenting for genetic testing for HNPCC. Carlsson and Nilbert (2007) noted that 
individuals who had cared for close family members reported experiencing emotional 
difficulties when first presented with the option of genetic testing for HNPCC. Similarly, 
McAllister (2002) noted that individuals who struggle with painful memories of having 
cared for and lost close family members may resist becoming engaged with their HNP 
risk. Past cancer experiences seem to be inextricably linked to coping strategies in 
complex ways. 
Becoming A ware of Genetic Testing and Living the Process 
The second construct of the model captures participants' experiences with genetic 
testing for HNPCC (i.e., prior counseling for, actual involvement in, and immediate and 
short-term reactions to receipt of results). Although genetic counseling sessions served to 
enhance individuals' understandings of what might or might not be in tore for them post-
testing, many of the participants in the current study were not prepared motionally for 
their test results. The apparent disconnect between understanding on a cognitive level and 
emotional acceptance was partially due to the extensive familial cancer presence, 
personal and fami ly beliefs about inheritance that impeded healthy proces ing of 
information conveyed from the Mendelian perspective, personal coping abilities, and 
openness of communication among members about cancer in the family. 
Support for the greater impact of subjective feeling states and lay beliefs about 
inheritance patterns on family members ' motivation to become involved in genetic 
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testing and initial reactions to, as well as adequate understanding of, test results is 
referenced in the research literature on genetic-based diseases (Bleiker eta!., 2003; 
Etchegary, 2004; McAllister, 2002; Meiser, 2005). These findings seem to be more 
developed in qualitative studies and the theoretical literature than in the quantitative study 
findings. Significantly, certain authors suggest that genetic counseling may not alter risk 
perceptions due to the prolonged exposure to familial cancer conditions, ingrained beliefs 
about inheritance, psychological states, and coping abilities (Brain eta!., 2005; 
McAllister, 2002, 2003). What the findings from the current study and the literature 
imply is that genetic counselors should pay as much attention to subjective feeling states 
as to how well the individual is processing the information being conveyed about genetic 
testing for a HNPCC gene mutation. Important to consider are the intensity and 
extensiveness of prior experiences with cancer in the family and/or on a personal level , as 
well as an individual ' s overall emotional well-being and coping abi lities. 
The interview transcripts of study participants served as constant reminders of the 
narrowness of the genetic testing event in comparison to the larger context of their lives 
prior to and following genetic testing. Nevertheless, the literature continues to attach 
great importance to the factors influencing the uptake of, as well as immediate reactions 
to, the genetic testing event (Aktan-Collan eta!., 2001; Bleiker et al. , 2003 ; Meiser, 
2005). Despite being sufficiently motivated to become involved in genetic testing for 
personal clarity of ri sk and to know the potential risk for the next generation, there was a 
general sense of ambivalence concerning the merits of their actions. 
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As the current study's findings suggest there are wide discrepancies in both 
carriers and non-carriers reactions to their test results. Some participants described the 
additional burden that knowing entailed (i.e. , not knowing when cancer will occur, what 
organ it will attack, how severe it will be, or how responsive it will be to treatment). With 
most of the evidence quantitative in nature, study findings suggest that there is minimal 
psychological and emotional harm from knowing one' s HNPCC risk (Bleiker et al., 2003; 
Braithwaite et al., 2006; Claes et al. , 2005; Heshka et al. , 2008; Meiser, 2005). 
Nevertheless, the current study's findings suggest that the psycho-emotional impact of 
knowing can become a major impediment to successful coping in the short- and long-
term. 
One of the ways in which understanding and acceptance is conveyed in the 
immediate post-testing period is in terms of how willing individuals are to engage in 
thinking about reasonable strategies/actions to help offset their risk. The current study s 
findings suggest that the information provided by genetic counselors was used to 
empower some participants to action. In contrast, other participants used this information 
to reinforce their need to be more selective in choosing screening programs that were 
more reasonable and manageable. In some instances this was due to how the individual 
perceived/actual dominance of one type of cancer over another (colon versus 
endometrial) and emotional or cognitive barriers to accepting the potential for variable 
expressivity across family clusters and/or multiple primaries in one person. Although not 
directly addressed in thi s manner, the theoretical insights gleaned from the relevancy of 
social cognition theory for research inquires into genetic-based di eases, especially the 
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interactive effects among multiple factors (e.g.,knowledge, belief, attitude, and behavior) 
reinforce study findings (Etchegary, 2004; Marteau & Weinman, 2006; Shiloh, 2006). 
The current study's findings also indicate that many of the participants felt inept 
about conveying the news of the HNPCC gene mutation within the family to others, 
especially children. The barriers/facilitators to sharing news about the HNPCC risk in the 
fan1ily highlighted by study participants included the openness of communication in the 
family as well as the perceived supportiveness of immediate and extended fam ily 
members. Comparable study findings have been reported in the literature on both the 
difficulties experienced in disclosing info rmation about HNPCC and genetic testing 
(Carlsson & Nil bert, 2007; Esplen et al. , 2007; Gaff et al. , 2005; Hamilton et al. , 2009; 
Koehly et al., 2003 ; Mesters et al. , 2005 ; Riper, 2005) as well as barriers to open 
communication and ways to overcome them (Beeker et al. , 2000; Neilson & Whynes, 
1995; Peterson et al. , 2003; Pylvanainen et a l. , 2006). 
Struggling to Adjust 
The third construct focuses on the long-term adjustment of individuals and 
families following confirmation of the presence of the HNPCC gene mutation. 
Adjustment post-genetic testing is best described as an evo lving state that ebbs and flows 
in response to critical events that are person or other-centered. In the current study, 
partic ipant 's ability to maintain a posi tive attitude was heavily influenced by the 
challenges posed by extensive screening protocols, new onset of cancer in the self or 
other close family members, the perceived/actual burden of belonging to these fami lies, 
the perceived/actual barriers to accessing care in a timely fashion, and the perceived 
supportiveness of health care providers and the health care system in facilitating ready 
access to care. Biesecker and Erby (2008) highlight the importance of viewing 
adjustment as a multidimensional construct, with many potential interacting factors 
altering its presentation at any point in time. 
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In the current study, both carriers and non-carriers oscillated between positive and 
negative feeling states. Many of them spoke about their search for stability, ongoing 
struggles to create a meaningful context for the self and other family members, and 
attempts to build inner strength. Past coping strategies were taxed, not only by personal 
issues, but also by the demands of thinking about and providing care to other family 
members affected by the di sease. Superimposed on thi s was mounting worry and concern 
for younger family members who could be potentially at-risk for HNPCC. Although 
ex isting literature provides limited insight into the depth and scope of the long-term 
struggles of individuals living within HNPCC families, several authors acknowledge that 
their complexity is shaped by the interaction of experiential cancer-based knowledge 
from the past and present as well as individua l coping styles (Bleiker et al. , 2003 ; 
d ' Agincourt-Canning, 2005; Kenen et al. , 2003 ; McAlli ster, 200 1, 2002). 
Several authors note that there is limited empirical evidence to make any definite 
conclusions about long-term psychosocial effects (Bleiker, 2003; Braithwaite eta!. , 2006; 
d ' Agincourt-Canning, 2005; Heshka et al. , 2008; Kenen et al., 2003 ; Meiser, 2005). The 
familial experiential context , such as having a parent affected by cancer at a young age 
or being exposed to a greater number of first-degree relatives affected by cancer, 
appeared to be associated with hi gher levels of distress following genetic test ing (Erblich, 
et al. , 2000; van Oostrom et a l. , 2003, 2007). As well , many researchers concur that 
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experiential knowledge and development of risk perceptions related to living with 
hereditary cancer and individual coping strategies are all important factors post-genetic 
testing (d' Agincourt-Canning, 2005; Kenen et al., 2003 ; McAllister, 2001 , 2002). 
Nevertheless, few findings exist on the extensive personal processing that occurs in both 
carriers and non-carriers in the months and years following testing. The existing research 
base also provides limited insight into how both HNPCC carriers and non-carriers 
struggle to create a meaning context, attempt to maintain a steady state in the face of 
personal issues, and cope with the demands of providing support to others in the family 
network. 
A significant finding from the current study was the relative importance attached 
to the presence of supportive others within the family - someone to share the burden of 
concern and care with - as well as the openness of carriers, affected and unaffected, to 
receive support from others. The value of the strength and stability offan1ily support 
systems for faci litating positive coping and adjustment at the individual and family level 
is receiving increased attention in the research literature on genetic-based diseases 
(Hamilton eta!. , 2009; Rolland & Williams, 2005; van Oostrom eta!. , 2003 ; van 
Oostrom et a l. , 2007). 
Although carriers were involved in screening prior to genetic testing, many of 
them highlighted additional challenges post-testing. The most important of these related 
to inconsistencies among providers concerning the extensiveness and frequency of 
required screening procedures for cancers, growing concerns about the intrusiveness of 
lifelong screening, increasing problems accessing formal supports (e.g., healthcare 
providers with adequate knowledge) and lessening certainty about the presence of a 
supportive health care system to help facilitate effective HNPCC management. 
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Several authors confirm the continued controversy over the suitable time intervals 
for colonoscopy and the appropriate scope and frequency of screening for related cancers 
in the management ofHNPCC (Lindor et al., 2006; Lynch et al., 2008, Schroy et al. , 
2007; Vasen, 2007). Similarly, the research evidence supports the potential negative 
impact of the procedures themselves and growing concerns/fears about procedure 
findings on long-term adherence to recommended protocols (Beeker et a!., 2000; 
Madlensky , Esplen, & Goel, 2004; Pylvanainen et al. , 2006; Wagner et al. , 2005). The 
growing importance of timely access to physicians/specialists with the requisite 
knowledge and skill base as well as a supportive health care system with ready access to 
diagnostic procedures has been identified by other researchers (Braithwaite et al. , 2006; 
Collins et al. , 2007; Geary et al. , 2007; Griffin et al. , 2007; Hadley et al., 2003; Lindor et 
al., 2006; Lynch et al., 2008; McAllister et al. , 2008b; van Oostrom et al. , 2006a). 
Interactive Effects 
The conceptual model, Confronting and Accepting the Chall nges of Living in 
Families with Genetic Linked Diseases, presents a broad framework for the pre, during 
and post-genetic testing period. Jts three constructs (i.e., living in families with a strong 
history of cancer, becoming aware of genetic testing and living the process, and 
struggling to adj ust to a positive/negative test result) are conjectured to exert a separate 
and interactive effect on each other in response to evolving chal lenges in one or more of 
them. The major unify ing thread connecting the constructs is defined as accepting the 
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challenge (e.g., testing and willingness to know personal status, living in families with 
cancer with a personal carrier or non-carrier status, enduring or finding strength from 
engaging in screening protocols, etc.). A couple of examples are needed to illustrate how 
this manifests itself within individuals and families. 
Individuals are present in all HNPCC families who need support services whether 
living alone or do not have strong family support structures. Other individuals who have 
a strong history of cancer in their families are struggling to cope wi th the implications of 
all of this for the self and others. Regardless of their personal affected status, they are 
dealing with a wide range of emotional and psychological issues that require therapeutic 
intervention if they are to develop a strong sense of resilience and maintain an optimal 
quality of life. 
The other significant finding is the negative impact that genetic testing for cancer-
related diseases is having on available health care resources. As long as HNPCC carriers 
are healthy, there is no problem with accessibility. In contrast, when these individuals 
move to the affected stage, the time between one screening and the next is very important 
to them physically and emotionally. When accessibility and timeliness pose problems, 
this has important implications for an individua l's ability to adjust psychologically and 
emotionally. 
Equa lly important, is the fact that physicians need to be more informed, not only 
about the presence of the HNPCC gene mutation in families, but a lso the multiple 
vulnerable sites for cancer and variant penetrance rates in fami lies. What this means for 
families is importance of encouraging individuals to keep up-to-date on new 
developments in this area and reinforce with other members the importance of 
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maintaining recommended screening schedules, especially when confronted with 
conflicting information about appropriate times and screening sites amongst physicians. 
One relevant model has smfaced since the original conceptualization of accepting 
the challenges. Importantly, Rolland and Williams (2005) have explicated the importance 
of the psychosocial impacts of developing a genetic disease based on the likelihood of 
developing the condition. These authors suggest that when a gene mutation is highly 
penetrant, the patient and family must ab orb the ce1tainty that the disease will occur. 
They have categorized HNPCC as a "variable likelihood" disease and therefore it carries 
that variable penetrance and, hence, variable li kelihood of psychosocial consequences. 
The concept of time phases provides a way fo r clinicians and fam ilies to think 
longitudinally about the course of an illness as an ongoing process with normative 
landmark transitions and changing demands. 
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CHAPTER6 
Limitations and Implications 
Limitations 
The purpose of this research study was to augment and confirm the conceptual 
model proposed in the original qualitative study and as a result the mode l constructs and 
properties served as a guide for the data analysis process. Using the mode l in this fashion 
was the main limitation in this study as there was an anticipation to reveal findings that 
were consistent with the model 's conceptualization, increasing the risk of researcher bias. 
Nevertheless, the researcher was aware of this study limitation and remained cognizant of 
the potential for bias, while reading and coding the transcripts and analyzing them for 
content. The findings from the exon 8 deletion participants did confi rm the model. 
However, pa11icipants did highlight new information that served to augment model 
properties reducing overlap and enhancing areas of significance, which minimized the 
bias potential. 
A second limitation of this study was the use of newly obta ined data in 
combination with data obtained from exon 8 de letion participants from the o riginal study. 
This meant five of the 12 interviews had been inde pendently reviewed, coded and rated 
as part of the o rig inal study analysis and therefore received additiona l attention and 
scrutiny increasing the risk of bias. Nevertheless, all 12 interv iews were analyzed under 
the context of the exon 8 deletion partic ipant grouping using the same data analysis 
process and each transcript was reviewed for major themes by two independent 
researchers to enhance rigor. Participant confirmation of interpretive summaries also 
added further credibility to the findings. 
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Finally, a common limitation for many studies on the genetic testing experience is 
the purposeful selection of participants from individuals who have been through the 
genetic testing process. These are the individuals that provide the richest and most 
relevant data, yet they have also received the benefi ts of genetic counseling and likely 
have had and will report healthy experiences with testing. Nevetiheless, study findings 
may be considered more trustworthy as participants in this study felt comfo rtable and 
provided genuine detailed information on their actual experiences prior to, during and 
following genetic testing. A lso sampling was guided by the emerging content and the 
model constructs and properties and a range of experiences was revealed offsetting the 
risk of bias associated with purposeful selection. 
Clinical Implications 
With the increased availabili ty of genetic testing fo r hereditary cancer conditions, 
health care professionals must have the app ropriate knowledge to as ist individuals and 
families with disease management. F indi ngs from this study have cl inical implications 
that serve to enhance the provision of genetic counseli ng, genetic testing and overall 
management of indiv idua ls and families with HNPCC. 
The impact of the experientia l context of cancer for individuals who belong to 
HNPCC fam ilies cannot be understated. Experiences wi th fami ly cancer significantly 
influence one's level of awareness, fo rmulation of risk perceptions and coping abil ities 
fo r managing the disease. T he variation and complex ity of individual and fam ily 
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experiences from living with HNPCC necessitates an individualized approach to the 
provision of genetic services. Consideration must be given to all aspects of the HNPCC 
condition, including the experiential impact of living in these families and the genetic 
testing process, as well as the short- and long-term adjustment to genetic test results and 
the concomitant formal and informal support requirements. Assessment tools are not yet 
available, but are required to effectively monitor and clinically manage individuals with 
hereditary cancer conditions. Clinical tools will allow health care professionals to assess 
an individual's level of preparedness, potential reactions to and supp01i needs for 
undergoing genetic testing for HNPCC. Meanwhile, genetics personnel should be alerted 
to some of the more significant psycho-emotional needs of individuals and families 
undergoing genetic testing for HNPCC. 
Not everyone is equally aware of or influenced to the same degree by the cancer 
that presents in the immediate family. For those most aware, often due to exposure to 
cancer in a parent or close relative at a young age, there may be a greater sen e of 
fatali sm towards the disease. Importantly, the outlook for the self and fo r others seems to 
vary depending on the degree of suffe ring and whether or not the parent or close relative 
with HNPCC succumbed to the disease. An individual' s outlook is an important factor 
shaping their sense of controllability of the disease. Genetics personnel need to be alert to 
variant levels of awareness of cancer in the fami ly and the closeness of re latives affected 
by the di sease a this influences comprehension, acceptance and emotional readiness to 
become informed of one ' s HNPCC risk status. 
The quality of the family relati ons is al o significant in shaping ri sk perceptions 
for HNPCC. When family cancer experiences strengthen family relations there seems to 
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be a greater appreciation of one's high-risk status and the need to be more attentive to 
one's health. Conversely, when cancer weakens family relations there seems to be 
decreased awareness, Jesser appreciation of being high risk and more negative outlook 
about being able to control the disease. Assessing family functioning in relation to the 
HNPCC events can help shed light on an individual's level of awareness and acceptance 
of high-risk status. Knowledge gained from this assessment can help genetic personnel 
identify those with strong and weak family support structures. Strong family structures 
suggest the presence of sufficient resources to help buffer stress and faci litate 
understanding and acceptance of carrier or non-carrier status. Conversely, weak family 
structures should indicate to genetics personnel that there is a need to provide additional 
cognitive and emotional support regarding risk and disease prevention. 
Genetics personnel must also remai n cognizant of the fact that full acceptance of 
the challenge to engage in testing often occurs over time at an individual ' s personal pace. 
Time may be required to assimilate and adjust to the high risk information and even more 
time to weigh the risks and the benefi ts of engaging in the process. It is also important to 
consider the age of those engaging in genetic testing for HNPCC, as younger individual' s 
in their teenage years or early adulthood are not always fu lly aware of the extent of 
cancer in the family and often are only introduced to it by health care professionals. 
Younger indiv iduals may also require add itional psychological, emotional and 
informational suppot1. 
Genetic counseling relies heavily on a Mendelian knowledge-sharing approach 
often emphasiz ing the cognitive aspects of testing and focusing on percentage of risk for 
colon and associated cancers, and related screening info rmation. Nevertheless, there is 
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growing support for further integration of strategies to assess and support the emotional 
aspects of testing in the short- and long-tem1 adjustment phase. Study findings indicate 
that many participants were unprepared for how they reacted emotionally to being 
informed of their HNPCC status. The apparent disconnect between understanding on a 
cognitive level and emotional acceptance of the results seems intimately related to the 
extent of family cancer, beliefs about inheritance, personal coping abilities and openness 
of communication in families in complex ways. Genetics personnel need to be cognizant 
of the subjective feeling states of individuals presenting for genetic testing and how well 
they are processing the information communicated to them. It is important also for 
counselors to consider the impact of past family cancer experiences on possible 
emotional reactions to the results of genetic testing. This event is an emotional one for 
many individuals and adequate emotional processing may require immediate and/or more 
intense short- or long-term psychological support. Individuals need to be given an 
opportunity to explore feelings and understandings openly and in a supportive 
environment. Contact to assess psycho-emotional support needs should continue in the 
short- and long-term periods after testing. 
Participants in this study were clear that the genetic testing event itself is narrow 
when compared to the larger context of their lives both before and after the testing event, 
with many describing a sense of ambivalence concerning the merits of taking part in 
genetic testing. Health care professionals need to embrace a broader conceptual view of 
being at risk for HNPCC. Being at risk is a condition that affects the individual and the 
family with both requiring support and management over time. Genetic testing for 
1-INPCC is one event along a continuum of lifelong disease management. The years prior 
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to and following the event are very significant to HNPCC families in terms of 
psychosocial and emotional impact and require further study and exploration. Health care 
professionals need to understand that even though patients accept and adjust to their 
HNPCC status, they may not always view it as a beneficial process over the long-term. In 
fact the impact of knowing one's results can impede successful coping. Information 
provided by genetics personnel may empower some individuals to act and embrace the 
demands of additional screening, while others are more selective in what they are willing 
and able to take on. Personal beliefs about inheritance, emotional and cognitive barriers 
to accept the range of cancer screening requirements may influence how individuals plan 
to proceed with screening after testing. Genetics personnel need to assess lay beliefs 
about HNPCC and explore how past experiences with cancer among loved ones influence 
and create ex isting beliefs because they are likely to provide clues to actual screening 
uptake. 
The burden of communication about hereditary cancer and testing for all family 
members at risk often rests with one individual, who is most often the one diagnosed with 
HNPCC or has been identified as a carrier. This burden requires further assessment as 
there are many important considerations around duty to tell , and how and when to inform 
others. Many study participants expressed a lack of confidence in relaying genetic test 
results especially to children and family members with whom they have had very little 
contact. Thi s finding suggests that individuals need continued support after testing to help 
them communicate with other family members. Families with less cohesion and 
decreased perceived support require greater assistance and support to en ure adequate 
disclosure of at-risk information. 
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There are many challenges after testing to maintain a positive attitude in the face 
of lifelong screening. Screening is viewed as burdensome and there is fear regarding the 
potential onset of new cancer onset in the self or others. Accessing care in a timely 
fashion is a concern and some individuals may need someone to help them navigate a 
complex health care system. Nurses in genetics and in the community are poised to help 
carriers navigate the health care system. Nurses need to advocate for HNPCC carriers to 
promote access to screening and to ensure communication of screening results by fami ly 
physicians and speciali sts. 
Concerns were also raised by participants about being able to continue with 
lifelong screening due to increasing problems with accessing formal supports, especially 
physicians. Most importantly, concerns were expressed about health care system barriers 
that interfere with the need for extensive and timely screening. Screening adherence is 
challenging, cumulative, and requires support at the family, social, and healthcare system 
level. Health care providers need to ensure access to screening. The family physician 
plays a crucial role in the management of 1-INPCC and together with nurses need to 
improve coordination of screening regimes. These findings also suggest that individuals 
want ongoing contact with health care providers in order to receive up-to-date 
information about HNPCC and its management. Long-term follow-up and support by the 
health care providers in genetics is necessary. 
Carriers and non-carriers describe a constant search for stabi lity as they continue 
to adjust to life after testing. Many highlighted the struggle to create a meaningful context 
for the self and others and build inner strength. The search for new coping strategies was 
apparent as participants spoke of the demands ofthinking and providing care to other 
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family members, as well as mounting worry and concern for younger family members, 
who may also be at risk. Supportive families made a difference as individuals had 
someone available to share the burden - openly discussing and disclosing fears and 
concerns while deriving emotional and psychological support. Further study is required 
on the social and fan1ily support needs and benefits for those with genetic-based disease. 
Nurses are poised to play an important role in the follow-up and support of individuals 
and families living with HNPCC. 
Nursing Implications 
Nurses are often the fi rst point of contact whether in the community o r acute care 
setting for individuals at risk for hereditary cancer conditions and as such must embrace 
the specific needs of this new group of patients. As such, nurses must have adequate 
knowledge about the basics of genetics and genetic-linked diseases. Individuals w ith a 
confirmed genetic link are at higher ri sk fo r cancer onset than those of the general 
population. Care for individua ls with a high ri sk for cancer conditions is largely 
preventative. N evertheless, the context of be ing in a high-risk fam ily and actually being a 
carrier of a cancer gene mutation has significant life long physical, psychosocial and 
emotional impacts. 
Nurses must have up-to-date knowledge of the Amsterdam I and 11 criteria as well 
as the Bethesda guide lines that outline HNPCC risk in order to be alerted to patients who 
are at increased risk for this di sease. Nurses also need to pay attention to young people 
who present w ith cancer, as well as individua ls with a family hi story ofCRC, and 
consider the ir potential HNPCC risk. Nurses should a lso assess the family structure, 
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patterns of communication and functional capacity in terms of how they inJluence one's 
awareness of the possibility of hereditary cancer risk as part of the decision to refer 
patients to genetic services. 
HNPCC carriers need to be supported by nurses in their screening efforts. They 
require navigation through the health system, timely follow-up and coordination to help 
them manage likely cancer events. As episodes of cancer appear, nurses need to be aware 
of the increased psycho-emotional needs of carriers, non-carriers and their fami lies and 
provide support and referral as necessary. Nurses must also be prepared to provide 
education on appropriate and ever-changing screening recommendations as they 
encounter individuals at risk for HNPCC. 
Nurse educators need to incorporate advances in cancer genetics into nursing 
curricula to provide students with the knowledge of this ever advancing fie ld . Patients 
who have undergone genetic testing have made the decision to live li fe knowing about 
their carrier or non-carrier status. As patients, these individuals have a more precise 
knowledge of cancer risk and therefore present in the health system as a unique 
population. Nursing education must prepare students for the range of patient perspectives 
that come with advances in genetics and technology. 
Nurse researchers must continue to make contributions, through qualitative and 
quantitative study, to advance knowledge of the care and management ofHNPCC and 
genetic testing. The long-term adjustment phase requires further prospective inquiry 
specific to those living with a known HNPCC carrier status. The role of soc ia l and family 
support for carriers and on carriers after testing remains largely unexplored and nurse 
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researchers are uniquely poised with expertise and well-developed theory on family and 
health systems to further advance knowledge in this area. 
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22 March 2004 
Dear 
Thank you for agreeing to review the materials associated with the qualitative 
component of the research study on individuals' experiences with genetic testing for 
hereditary colorectal cancer. We are asking people to share their experiences in a face to 
face interview in order to explore more deeply their thoughts and feelings surrounding 
genetic testing. 
Enclosed you will find a summary of the study and two consent forms for review at your 
convenience. If you require more information about the study and the extent of your 
involvement, please contact Jackie Stokes at 777- 6738 or the toll free number at 1-888-
908-4988. Jackie is the research co-ordinator for both the quantitative and qualitative 
components of this study. She will be contacting you in 3 to 4 weeks to confirm your 
interest in participating in the qualitative phase. 
We appreciate your cooperation. We hope the answers you provide wi ll help enhance the 
care of future patients and families. 
Yours sincerely 
Christine Way, PhD 
Principal Investigator 
NL Colorectal Cancer Study 
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Brief Overview of Research Study 
Title: Psychosocial and Behavioral Impact of Predictive DNA Testing on 
Hereditary Colorectal Cancer 
Investigators: Dr. Christine Way, Dr. Mary Jane Esplen, Dr. Jane Green, Robert 
Meadus and Jackie (Stokes) Fiander 
Objectives of the study: 
1. To explore the meaning of genetic testing for individuals at risk for developing 
hereditary colorectal cancer. 
2. To develop a greater understanding of the impact of genetic testing for colorectal 
cancer on individuals who receive positive or negative results. 
3. To identify relevant information that will facilitate the provision of counsel ing 
programs to more adequately address the needs of individuals belonging to 
families with documented hereditary colorectal cancer. 
Rationale for the study: 
Limited research has been conducted on the impact of genetic testing for individuals at 
risk for hereditary colorectal cancer. Genetic testing provides an opportunity to more 
precisely predict an individual's risk of developing these cancers. Still, with the abi li ty to 
predict or anticipate health threats may come fear, worry, and distress. Also, there is 
limited insight into how such testing influences screening and health practices. 
Brief description of the study: 
The proposed study will attempt to capture individuals' experiences with genetic testing 
for hereditary colorectal cancer in NL families. Each participant will be asked to 
pm1icipate in two interviews. During the first interview, which will last approximately 
60 to 90 minutes, the interviewer will focus on your experiences with genetic testing, 
your reasons for considering genetic testing, and the impact of test results on you and 
your family . Jn the second interview, you will be asked to confirm a summary of the 
main points addressed in the first interview and provide any additional information that 
may help faci litate our understanding of your experience. 
Procedure for obtaining consent: 
A written, informed and witnessed consent wi ll be obtained prior to the first scheduled 
interview. 
Proposed staring date: 06/0 I /04 
Appendix B 
Consent Form 
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October 2003 
Faculty of Medicine, Schools of Nursing and Pharmacy of Memorial 
University of Newfoundland; Health Care Corporation, St. John's; Newfoundland 
Cancer Treatment and Research Foundation 
Consent to Take Part in Health Research 
TITLE: Psychosocial and Behavioral Impact of DNA Predictive Testing for 
Hereditary Non-Polyposis Colorectal Cancer (HNPCC) 
INVESTIGATOR(S): Dr. Christine Way (709-777-6872), Dr. Mary Jane Esplen 
(416-340-4736), Dr. Jane Green (709-777-6242), Robert Meadu (709-777-6716) and 
Jackie (Stokes) Fiander (709-777-6738) 
SPONSOR: 
You have been asked to take part in a research study. It is up to you to decide whether to 
be in the study or not. Before you decide, you need to understand what the study is for, 
what risks you might take and what benefits you might receive. This consent form 
explains the study. 
The researchers will: 
• discuss the study with you 
• answer your questions 
• keep confidential any information which could identify you per onally 
• be available during the study to deal with problems and answer questions 
If you decide not to take part or to leave the study this will not affect your normal 
treatment. 
1. Introduction/ Background: 
You are being asked to participate in a research study of individuals receiving genetic 
testing for colorectal cancer. Very little is known about how people experience thi 
type of testing or how test results may or may not influence their decision to 
participate in recommended screening or treatment programs. This information may 
help improve the quality of genetic counseling services avai lable to individuals and 
their fam ilies. 
I. Purpo e of study: 
The purpo e of this study is to explore individuals ' experiences with genetic testing 
for colorectal cancer and perceptions of recommended screening programs. The 
study has the potential to increase our understanding of difficult aspects of these 
experiences, and provide useful information on how Dounseling services can be 
improved to address individual needs. 
2. Description of the study procedures and tests: 
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You are being asked to participate in two interviews which will be conducted at a 
place and time that is convenient for you. Interviews will be audiotaped (with your 
permission). Tapes will be transcribed word for word and used solely to help the 
interviewer recall the details of your conversation. 
During the first interview you will be asked to reflect upon your experiences with 
genetic testing and describe any thoughts and feelings that you may recall about it. 
You will also be asked to comment upon the least and most helpful aspects of any 
information given to you about your test results and recommended screening 
programs. 
Within a three to four week period, you wi ll be given an interpretive summary of the 
first interview and arrangements made for a second interview. During the second 
interview you will be asked to confirm whether or not the interpretive summary 
accurately reflects your experiences with genetic testing, and provide any additional 
information that you may consider important for clarifying your experiences. 
4. Length of time: 
The first interview will take approximately 60 to 90 minutes, and the second about 30 
minutes. Both interviews should be completed within two months. 
5. Possible risks and discomforts: 
It is possible that during the interview you may reflect upon some difficult moments 
associated with g netic testing. This may cause you to experience some anxiety and 
discomfort about di sclosing your thoughts and feelings. You may refuse to answer 
any interview questions, and terminate the interview, as well as your participation in 
this study, at any time. The interviewer may also terminate the interview and refer 
you back to your genetic counsellor if it is determined that you could benefit from 
additional counselling serv ices. 
A ll information that you provide will be kept strictly confidential, secured in a 
locked file, and accessible only to the research team. Your name wi ll not appear on 
the audiotape or written copy, and any names that you might mention during the 
course of the interview will be removed from the transcribed texts. 
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6. Benefits: 
It is not known whether this study will benefit you. 
7 . Liability statement: 
Signing this form gives us your consent to be in tll.is study. It tells u that you 
understand the information about the research study. When you sign this form, you 
do not give up your legal rights. Researchers or agencies involved in this research 
study sti ll have their legal and professional responsibilities. 
8. Questions: 
If you have any questions about taking part in this study, you can meet with the 
investigator who is in charge of the study at th is institution. That per on is: 
Dr. Christine Way: (709) 777 - 6872 
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Or you can talk to someone who is not involved with the study at all, but can 
advi e you on your rights as a participant in a research study. This person can 
be reached through: 
Office of the Human Investigation Committee (HIC) at 709-777-6974 
E mail: hic@ mun.ca 
Signature Page 
srudy rille: Psychosocial and Behavioral Impact of DNA Predictive Testing for 
Hereditary Non-Polyposis Colorectal Cancer (HNPCC) 
Name of principal investigators: Dr. Christine Way and Dr. Mary Jane Esplen 
To be filled out and signed by the participant: 
Please check as appropriate: 
I have read the consent [and information sheet]. Yes { } 
I have had the opportunity to ask questions/to discuss this study. Yes { } 
I have received satisfactory answers to all of my questions. Yes { } 
I have received enough information about the study. Yes { } 
I have spoken to Dr. and he/she has answered my questions 
Yes {} 
I understand that I am free to withdraw from the study Yes { } 
• at any time 
• without having to give a reason 
• without affecting my future care [student status, etc.] 
I understand that it is my choice to be in the study and that I may not benefit. 
No {} 
No {} 
No {} 
No {} 
No {} 
No {} 
Ye { } No { } 
l agree that the study doctor or investigator may read the parts of my hospital 
Yes { } No {} 
records which are relevant to the study. 
I agree to take part in this study. Yes { } No { } 
Signature of participant Date 
Signature of witness Date 
To be signed by the investigator: 
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I have explained this study to the best of my ability. I invited questions and gave answers. 
1 believe that the participant fully understands what is involved in being in the study, any 
potential risks of the study and that he or she has f reely chosen to be in the study. 
Signature of investi gator Date 
Telephone number: 
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Interview Script 
We are interested in your experiences with genetic testing for hereditary colorectal cancer 
from the time you first learned about the testing right up to now. We would like for you 
to take some time to reflect upon these experiences and share with us your perceptions of 
the genetic testing process as you saw it. You can share any thoughts, feelings, and ideas 
about your experiences. Feel free to talk about whatever comes to mind. 
Examples of Probes/Questions to Facilitate the Interview 
3. Could you think back to when you first learned that you were eligible for genetic 
testing for hereditary colorectal cancer and what that meant to you then? 
4. Can you recall a significant personal experience around genetic testing for 
hereditary colorectal cancer that left a lasting impression in your memory? If so, 
when and how did this experience occur? How important was it for you at the 
time? Do you believe that it is still important? (Probes: Are you able to identify 
any particular experiences that left you feeling good/bad about things/yourself? 
Can you recall a significant event that reinforced/diminished your confidence 
about how well prepared you were to deal with the results and potential 
problems/needs in a comprehensive manner?) 
5. How do you feel about genetic testing and hereditary colorectal cancer in general? 
What are some of the positives? Negatives? 
6. How has this experience changed the way you look at things/life? 
7. How has this experience influenced your relationships with other family 
members? 
8. How would you rate the overall genetic testing experience? Are there particular 
aspects of these services that could be improved? What measures would you like 
to see implemented/changed that could potentially improve the quality of genetic 
testing services? (Probes, if not mentioned: Access to community resources, such 
as diagnostic faci lities, specialists, genetic counselors, hospitals, etc. ; access to 
other sources of information). 
9. Are there any other comments or thoughts that you would like to share with us 
about your experiences with genetic testing for hereditary colorectal cancer? 
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